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Abstract 
Myogenesis is studied as an example of vertebrate cell type determination and 
differentiation mainly due to the cloning and characterization of genes, both regulators and 
downstream structural genes, specifically expressed in this lineage. The studies presented 
in this thesis describe the regulation and function of the MyoD family of myogenic 
regulatory factors (MRFs) in the developing mouse embryo. 
There are four known MRFs (MyoD, Myf-5, myogenin, MRF4/herculin/myf6) in 
vertebrates; all are exclusively expressed in skeletal muscle and their progenitors, but each 
with a unique and dynamic pattern. The individual function of one of these, MRF4, was 
tested by gene disruption via homologous recombination. MRF4 is required for proper 
muscle formation in a specific domain of the axial lineage during embryogenesis. Later in 
development, the muscle phenotype is rescued apparently by cellular compensation, 
suggesting partial redundancy between MRF members. However, an unexpected rib 
pattern formation defect was observed that caused the death of MRF4 null mice at birth. 
An inductive signal from muscle precursors to rib progenitors is postulated to be the cause 
for this malformation. 
A differentiated cell is usually considered to be a terminal phenotype. However, the 
MRFs, when force expressed, have the unique capacity to transform various differentiated 
cells into a myogenic phenotype. Such a switch in phenotype seems to occur during 
normal perinatal development of esophagus muscle, as these cells transdifferentiate from a 
functional smooth type to skeletal muscle by sequentially expressing the MRFs, and then 
skeletal muscle-specific structural genes. This is one of the few examples of 
transdifferentiation that occurs during normal development of vertebrates. 
The potent capacity of the MRFs to convert cells to a myogenic phenotype requires 
tight regulation of MRF expression as well as modulation of their function. Transgenic 
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mice containing certain regulatory sequences from the Myf-5 locus, the first MRF to be 
expressed in all muscle lineages studied, drives the expression of a marker gene specifically 
in the early head but not trunk muscle precursors. This implies distinct regulatory 
pathways of initiating muscle determination in the two lineages. Furthermore, the head 
lineage is unique since Myf-5 is expressed at least three days before any of the other MRFs 
or muscle-specific difterentiation genes are detectable, and suggests that Myf-5 function is 
under negative control. 
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The Role of the MyoD Family Regulatory Factors 
in Vertebrate Myogenesis 
2 
How a single cell, the fertilized egg, gives rise to the diverse mature cell types in 
multicellular organisms is a fundamental question in developmental biology. It is generally 
accepted that multi potential progenitor cells undergo a series of stepwise changes in cellular 
phenotype, ultimately leading to a specific differentiated cell type. These changes 
correspond to the changing repertoire of genes expressed at each step of development, and 
insight into the molecular pathways that control these developmental progressions has 
recently emerged. For example, in the skeletal muscle lineage, the cloning and 
characterization of the MyoD family of myogenic regulatory factors (MRFs) have been 
crucial in the study of myogenic cell fate determination and differentiation (Weintraub, 
1993). The MRFs (MyoD, myogenin, Myf-5, MRF4/herculin/myf6) belong to the basic-
helix-loop-helix (B-HLH) class of transcription factors, and have been thoroughly studied 
in cell culture, where they exhibit the extraordinary ability to convert naive fibroblasts and 
other permissive cell types into a myogenic phenotype. An underlying goal of my thesis 
research has been to instead focus on understanding the regulation and function of the 
MRFs in the context of the intact developing embryo. These and other studies in the animal 
now highlight three important concepts: first, it has become clear that each of the four 
MRFs have substantially different roles during myogenesis. Second, within specific 
groups of muscle cell precursors, the expression and regulation of -- and the requirement 
for -- individual MRFs seem to be surprisingly heterogeneous. Third, MRFs also seem to 
have a non-autonomous function in inducing proper rib development. With this new 
understanding of the MRFs in hand, I will compare mammalian skeletal myogenesis with 
other regulators and developmental systems that involve cell type specification. 
MRFs and Myogenesis: 
The study of myogenesis in cell culture has given an impression of relative 
simplicity for the process by which the MRFs, as potent transcription factors. orchestrate 
myogenic differentiation. Howevt!r, myogenesis in vivo occurs within the context of 
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mesodennal specification and patterning, and involves a hierarchy of cell-cell interactions. 
These facts. together with the multilineage origin of skeletal muscle in vertebrates, make 
the complex process of myogenesis difficult to mimic in cell culture experiments. Thus, 
the need to investigate the MRFs in vivo is critical. For the MRFs to play a direct role in 
the myogenic determination and/or differentiation process in vivo, it would first be 
expected that these regulators be expressed in skeletal muscle and their precursors before 
overt differentiation of muscle. Second, the MRFs must be necessary for myogenesis to 
occur. Indeed, the MRFs are specifically expressed in the skeletal muscle lineage at all 
timepoints, and each MRF has a unique and dynamic expression pattern within the 
developing animal (Buckingham, 1992; Smith et al., 1994). Germline gene disruption 
experiments in the mouse are now providing further evidence that individual MRFs play a 
crucial hut distinct role in myogenic determination and differentiation. 
Origin of muscle in vertebrates: 
Before characterizing the molecular pathways of myogenesis, it is necessary to have 
an understanding of the origin of skeletal muscles in vertebrates. While cardiac and 
smooth muscle arise from lateral mesoderm, skeletal muscle is mostly derived from dorsal 
paraxial mesoderm (Wachtler and Christ, 1992). In the trunk and tail regions, the paraxial 
mesoderm is first segmented into somitic blocks in a rostrocaudal progression on both 
sides of the neural tube. Under the influence of signals from epidermis, neural tube and 
notochord, these somites subdivide into dermomyotome (muscle and skin precursors) and 
sclerotome (cartilage and hone precursors) and subsequently the dermomyotome further 
segregates into myotome and dermatome. The myotome, like other parts of the somite, is a 
transient embryonic structure. The skeletal myocytes that differentiate there are few in 
number relative to the adult musculature, and their specific fate is unknown; however, they 
are thought to contribute to parts of muscles of the back (Christ and Ordahl, 1995). Lateral 
somitic cells contain at least one separate lineage of muscle precursors with respect to 
morphological criteria and molecular markers. These cells migrate laterally and ventrally to 
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form the muscles of the limbs and the body wall (Christ and Ordahl, 1995). Muscles of the 
head are derived from a third independent lineage which arise from prechordal plate and 
anterior (non-segmented) paraxial mesoderm. A majority of these muscle precursors 
migrate ventrally to visceral arches before they reach their final location and differentiate 
(Noden, 1991; Couly et al., 1992). 
MRFs are expressed in a distinct and dynamic pattern in vivo: 
The MRFs are expressed in all three lineages described, and each MRF has a 
unique spatiotemporal expression pattern. The best studied lineage is that of the myotome. 
In the mouse myotome. Myf-5 is the first muscle-specific gene to be expressed at 
embryonic day 8 (E8, 4 somites stage). and its expression precedes overt differentiation of 
myocytes. RT-PCR studies have also shown low-level expression of Myf-5 prior to 
somite formation, in the presumptive segmental plate (Kopan et al., 1994). Myogenin 
expression quickly follows that of Myf-5 at E8.5. MRF4, which is highly expressed in 
adult musculature, is expressed transiently in myotomes between E9 and El 1.5. MyoD 
expression appears last in myotomes starting at El0.5. More recent studies with MRF 
antibodies have shown a surprising subdivision of the myotome with respect to MRF 
expression, so that each MRF is expressed in distinct spatial domains of the myotome; for 
example, Myf-5 and MyoD are present in separate regions of the myotome, with Myf-5 
being expressed dorsomedially, while MyoD expression appears in more ventrolateral 
myotomal cells (Smith et al., 1994). Hence, although MyoD is the last to be expressed in 
myotomes, it is turned on in cells that have probably not expressed any other MRFs, 
making MyoD the first MRF to be expressed in a subpopulation of myotomes. 
MRF expression in limb bud and visceral arch expression differ from that of 
myotomes by at least two different ways. First, MRF4 is not expressed in these lineages 
during embryonic development, and only appear at fetal stages (E16.5), during the second 
wave of MRF4 expression~ second, the other MRFs are not expressed in the muscle 
precursors prior to their completion of ventral migration, and are therefore temporally 
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delayed with respect to MRF expression and differentiation of myotomes. One interesting 
explanation for the lack of early MRF expression in these lineages is perhaps to protect 
these cells from prematurely entering the differentiation pathway w.hile they migrate long 
distances in the embryo. Myotomal cells do not migrate substantially. and differentiate 
early during somitogenesis. 
Role of MRFs in myogenesis: determination vs. differentiation 
Despite their complex and distinct expression patterns in the developing embryo, all 
four MRFs have similar potential to recruit cells to a myogenic phenotype in culture. This 
apparently simple observation is somewhat complicated because the MRFs have the 
capacity to auto- and cross-regulate one another; this has made it difficult to discern the 
individual roles of the MRFs in cell culture experiments (Weintraub et al., 1991). This 
issue has been partly clarified by recent gene disruption experiments. Although animals 
lacking either Myf-5 or MyoD have mild muscle phenotypes at birth (Braun et al., 1992; 
Rudnicki et al., 1992), mice lacking both Myf-5 and MyoD do not contain any skeletal 
muscle at birth, and lack cell mass where skeletal muscle would normally be present 
(Rudnicki et al., 1993). This suggests that Myf-5 and MyoD are partially redundant for 
muscle formation, but at least one of them is required for myogenic determination. Further 
proof for the role of Myf-5 in muscle detennination is coming from ongoing unpublished 
work in Buckingham lab, where Myf-5 gene was replaced with the bacterial lacZ gene. 
Mice homozygous for this transplantation allele show expression of lacZ in non-muscle 
cells such as dermis and cartilage cells. The simplest interpretation is that, in the absence of 
Myf-5 function. cells nonnally determined to become muscle cells are recruited to other cell 
fates. It is interesting that these cells, initially cued to turn on Myf-5, continue to reflect 
that myogenic 'assignment' by continuously expressing lacZ even after their recruitment to 
new cell fates. 
A different phenotype is observed in mice lacking a functional myogenin gene. 
These animals form proper muscle precursors in number and morphology, however, there 
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is a gross lack of differentiation and fiber formation in vivo, which suggests a more 
'downstream' (compared to Myf-5 and MyoD) and a direct role of myogenin in carrying 
out the differentiation process (Hasty et al., 1993; Nabeshima et al., 1993; Venuti et al., 
1995). 
Since the MRFs have a very similar activity in ectopic expression studies. it is not 
yet obvious if the differences in MRF knockout phenotypes are due to subtle differences in 
the function of the particular proteins, or that the differences are simply dictated by the 
regulatory sequences that control their pattern of expression. Homologous recombination 
experiments where one of the MRFs is replaced with another will differentiate between 
these possibilities. 
The role of MRF4 appears to he more complicated, and initial analysis show that it 
might have a dual role during development: an embryonic and a postnatal function in 
myogenesis. During somitogenesis, as I will discuss below in more detail, MRF4 is 
necessary for the formation of a subset of myotomal precursors (Patapoutian et al., 1995a); 
MRF4 seems to have an important function in postnatal muscle development as well, 
judged by the upregulation of myogenin in adult muscle (Zhang et al., 1995). More 
detailed analysis of these null mice, together with combination double knockout 
experiments with other MRFs will clarify the importance of MRFs in determination and 
differentiation of muscle (Braun and Arnold, 1995). The summary of MRF knockouL'> is 
presented in Table I. 
Different MRFs are required for distinct myotomal domains: 
Detailed studies of the MRF knockouts are reinforcing the idea of cellular 
heterogeneity within the myotome. Based on the MRF protein expression pattern described 
above (Smith et al., 1994), as well as the analysis of Myf-5 (Braun et al., 1994) and MRF4 
(Patapoutian et al., l 995a) null mice during embryogenesis, we proposed the existence of 
three distinct myogenic regulatory programs in the somite (Myl-My3), which correlate 
temporally and spatially with three waves of cellular recruitment to the expanding myotome 
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(primary, secondary, tertiary myotomes). This is illustrated in Fig. 1 and discussed in 
more detail in the second chapter of my thesis. Each myotomal subdomain expresses a 
distinct set of the MRFs, and its formation is dependent on those regulators. Myf-5 null 
mice show a lack of the Myl and My2 programs, and this deficit is rescued later during 
embryogenesis by MyoD expressing My3 program (Braun et al .• 1992; Braun et al., 
1994). A similar situation seems to occur in MRF4 null mice: The second of these 
programs (My2) was severely affected in the MRF4bhl/bhl mice judged by the lack of the 
secondary myotome at the cellular level, but this deficit was later rescued by the third 
program. These data suggest that the formation of the primary wave of myogenesis is 
dependent on Myf-5; the secondary wave, on Myf-5 as well as MRF4; while the third 
wave, on MyoD. Myogenin. although expressed very early during myotomal formation, 
seems to play only a later role in differentiation during fetal stages (Venuti et al., 1995). 
The idea of a compartmentalized myotome raises an important point on the mechanism of 
compensation observed in the muscle deficits in MRF null mice. There are two possible 
mechanisms of compensation: 1) molecular comnensation, where compensation occurs 
within a single cell, as one MRF can perform the same function as another; 2) cellular 
compensation, where a separate lineage of cells expand and repopulate the cellular deficit 
caused by the lack of a single MRF. Recent evidence from MRF knockout mice all point 
toward cellular compensation as the mechanism involved in myotomal compensation. 
However, from ectopic expression experiments both in vivo and in vitro, it is obvious that 
MRFs are capable of crossregulation within a cell. This leaves open the possibility of 
molecular compensation in vivo in other settings (Weintraub et al., 1991; Miner et al., 
1992). For example, upregulation of Myf-5 in MyoD null adult mice (Rudnicki et al., 
1992). and upregulation of myogenin in MRF4 null mice (Zhang et al., 1995) can be 
explained by either compensatory mechanism. However, cellular compensation seems 
increasingly attractive for these cases as well, since if compensation was at a molecular 
level, it would be necessary to postulate that MyoD normally represses expression of Myf-
8 
5. and MRF4 normally represses the expression of myogenin. Although possible, there is 
presently no evidence to date for such negative regulatory loops within the MRF circuitry. 
Non-autonomous function of the MRFs: 
One of the most interesting and unexpected results from the MRF knockout studies 
are the observed rib morphogenetic phenotypes observed in these mice. This was 
surprising since MRFs are not expressed in ribs or their precursors, and as transcription 
factors, are thought to act in a cell autonomous fashion. All the MRF null homozygotes, 
except MyoD, show some rib abnormalities. Myf-5 null mice show very severe truncation 
of ribs, while myogenin and MRF4 show more of a rib patterning defect (Braun et al., 
1992; Hasty et al., 1993; Nabeshima et al., 1993; Braun and Arnold, 1995; Zhang et al., 
1995; Patapoutian et al., 1995a). The most straightforward interpretation of the rib 
phenotypes is to postulate an interaction between muscle and rib precursors during early 
somitogenesis. Indeed, the myotomal cells are in close proximity to sclerotomal cells (rib 
precursors) during this time in development, and suggests that the basis for the rib 
anomalies in the MRF null animals are mainly due to signals or scaffolding produced by the 
myotome. One such possible signal could be FGF-6 which is expressed specifically in 
skeletal muscle during emhryogenesis and belongs to the family of fibroblast growth 
factors (Han and Martin, 1993; deLapeyriere et al., 1993). I found that its levels are 
strongly downregulated in myotomes of MRF4 null mice and is described in chapter 3 of 
my thesis. It is relevant that FGF family receptors such as FGFR-1 and FGFR-2 are 
expressed in sclerotomal cells, but no known candidate ligands have been identified within 
the sclerotome itself (Peters et al., 1992; Yamaguchi et al., 1992). Recent unpublished 
studies in Arnold lah have also shown that, FGF-6 and TGF-b together, can induce 
cartilage formation in vitro. 
Regulation of MRF Expression and somitic patterning: 
Given the varied and dynamic expression patterns of the MRFs, and their 
developmental capabilities discussed above, a central problem is to understand what 
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regulates their expression. Isolation and characterization of regulatory sequences of MRFs 
in transgenic mice have proven useful, and also present a method by which events in 
myogenic determination temporally preceding expression of the MRFs can be studied. 
Myogenin regulation seems to be the most straightforward (Cheng et al., 1993; Yee and 
Rigby, 1993). Approximately 150 bases of 5' tlank DNA is sufficient for correct 
recapitulation of myogenin expression, and two essential motifs in these sequences are 
consensus binding sites for b-HLH family members and RSRF (related to s.erum response 
factor) proteins. This reinforces cell culture experiments that the MRFs are under strong 
cross-regulatory loops. MyoD, Myf-5, and MRF4 regulation is more complicated. An 
enhancer for MyoD transcription is found in a region of 258bp localized about 20 kb 5' 
flank of the site of transcriptional initiation; these sequences contain b-HLH consensus 
binding sites, but activation of transcription is not dependent on these sites (Goldhamer et 
al., 1992; Goldhamer et al., 1995), reinforcing the idea that MyoD can be activated 
independent of previous MRF expression as seen in Myf-5 null mice (Braun et al., 1994). 
Factors that activate MyoD transcription are not known as of yet. 
For Myf-5, regulatory elements that appropriately initiate activation in head but not 
trunk muscle precursors have been identified (Patapoutian et al., 1993), and this is the 
focus of the fourth chapter of my thesis. Thus, Myf-5 expression rely on different 
regulatory regions of this gene in different muscle lineages. This argues that muscle 
determination might be under sepamte molecular pathways in different lineages, a view that 
is not surprising given the different cellular environments in which visceral arch and 
myotomal cells are induced to express Myf-5 and initiate myogenesis. Regulatory 
sequences that control the late. hut not early. expression of MRF4 has also been isolated 
(Patapoutian et al .• 1993). 
MRF4 and Myf-5 are linked in mammalian genome; in the mouse, the two 
transcript start sites are 7kh apart. The immediate upstream sequences of the two genes' 
are not sufficient for complete recapitulation of the endogenous expression patterns, and 
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suggests that this locus might be under complex regulation. where the linked state of Myf-5 
and MRF4 is perhaps essential for correct expression. Indeed, unpublished results from 
Rigby lab have shown that some Myf-5 regulatory sequences reside within the MRF4 
gene. This complex regulatory locus provides a possible explanation for the diverse 
phenotypes achieved by knocking out different regions of the MRF4 gene (Braun and 
Arnold, 1995; Zhang et al., 1995; Patapoutian et al .• 1995a). Three different groups have 
generated targeted disruption alleles of MRF4, and the phenotypes vary considerably (Fig. 
2). The Arnold construct unintentionally created a null allele of Myf-5 gene as well; it acts 
as a double mutant and the dominant phenotype is a Myf-5 phenocopy. The other two 
alleles are more comparable, and it is not obvious as of yet if the differences are due to 
partial cis effects on Myf-5 expression, or perhaps genetic background variations (refer to 
table I. Fig 2 and chapter 2). 
The complicated crossregulatory network between the MRFs, as well as the 
difficulty of narrowing down regulatory elements in transgenic experiments make it 
difficult to use the regulatory sequences of MRFs to identify the signaling events that lead 
to MRF expression. One alternative way of asking this question is by in vivo 
transplantation or in vitro culture of tissue explant techniques, where undifferentiated and 
unpattemed somites are put in proximity to potential inducing tissues of myogenesis, and 
MRF expression. Although such studies are at an early stage at this time and several 
studies report apparent contradictions, several consensus conclusions appear to be 
emerging. The notochord and the floor plate, perhaps through the hedgehog protein, 
specify a sclerotomal (ventral) somitic fate. while signals from the surface ectodenn and 
neural tube specify a dermomyotomal (dorsal) phenotype (Fan and Tessier-Lavigne, 1994). 
When tested specifically for myogenic differentiation or MRF expression. the neural tube is 
the strongest candidate inducer. The role of the notochord in myogenesis is controversial. 
and results claiming both induction and repression have been reported (Stem and 
Hauschka, 1995; Munsterberg and Lassar, 1995; Buffinger and Stockdale, 1995). 
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Although no molecules are yet identified that could induce myogenesis in such a system, it 
has been recently shown that a diffusible factor from the neural tube is capable of inducing 
myogenic activity in the somites (Bullinger and Stockdale, 1995). 
Negative regulation of MRF activity, and myogenic expansion: 
Transcriptional activation of the MRFs is only the first level of regulation. In cell 
culture, the MRFs are expressed in dividing myoblasts, but their activity is negatively 
regulated by various mechanisms, until the time of differentiation (Weintraub et al., 1991). 
One set of negative regulator of the MRFs are the Id family members, which are HLH 
proteins lacking a functional DNA-binding basic region. Id-I is present in myoblasts in 
culture and binds directly to the MRFs or their partners and repress their DNA-binding 
ability (Benezra et al .• 1990; Neuhold and Wold, 1993). Downregulation of Id-1 is 
observed under differentiation conditions, and this is thought to unleash the MRFs to carry 
out the myogenic differentiation process. However, the in vivo domain of somitic 
expression of Id-1 is largely exclusive from and precedes any MRF expression (Wang et 
al., 1992). This raises multiple questions. First, the technique used (radioactive in-situ 
hybridization) might not he sensitive enough to pick up a small number of coexpressing 
cells. Second, only myotomal expression has been examined carefully, where 
differentiation genes are expressed almost immediately after Myf-5 is first detected, and 
where there might not he a need for an global negative regulation of MRF expressing cells. 
Other muscle lineages, such as those of the head precursor visceral arches, express Myf-5 
three days before any muscle-specific differentiation gene is expressed, and might be 
coexpressing positive and negative HLH regulators, and this issue is discussed in more 
detail in chapter five of my thesis (Patapoutian et al., l 995h). Finally, there are at least 
three other Id molecules, and hence other closely related negative regulators might be 
expressed in some MRF-expressing cells. In fact. while no detailed expression studies for 
the other Id molecules are yet available, comparison of the expression of Myf-5 and m-
twist, another b-HLH protein that can repress the action of the MRFs, showed that these 
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RNAs appear to be expressed in a critical domain at the dorsal lip region of the myotome 
where new MRF expressing cells are thought to originate (Yun et al., 1995). Alternative 
mechanisms of MRF activity regulation such as phosphorylation of the MRFs have also 
been suggested (Li et al., 1992) and are discussed in detail by Lassar et al. (1994), where 
posttranslational modifications of the MRFs could render them inactive until the appropriate 
time of cell cycle withdrawal and differentiation. 
The negative regulation of MRFs is a critical issue, because it provides a plausible 
mechanism for the muscle expansion that occurs throughout embryogenesis. A model in 
the field postulates that some of the cells expressing MRF differentiate immediately, while 
others are kept under negative regulation, continue to divide, and serve as the myoblasts 
that will populate the next myogenic expansion and differentiation. Whether dividing 
myoblasts that express MRFs are present within the myotome is not yet known. Another 
possibility that has been largely ignored is that MRF expressing cells do not usually persist 
under negative control for an extended period of time in vivo, and most often they 
differentiate soon after initiation of MRF expression. In this scenario, expansion of 
myogenic cell mass could be achieved if already differentiated muscle cells or other 
proximal tissues such as the neural tube can continuously induce MRF expression in their 
neighboring non-myogenic cells. At least two separate inductive events are already 
postulated for myotomal formation, one signal to activate Myl; another, for My3. The 
expression of negative regulators of MRFs (e.g.: Id-I, Hox-7.1, m-twist) in neighboring 
sclerotomal and dennotomal cells might serve to ensure that the myogenic induction does 
not over-extend and take over the rih and dermis precursors. It is important to note that the 
two models are not mutually exclusive, and during emhryogenesis both methods are 
probably used. according to the lineage and cell environment. 
The MRFs and switch in differentiated phenotype: 
The in vivo role of MRFs is clear with respect to recruiting naive, uncommitted 
cells to a myogenic phenotype. However, when ectopically expressed, MRFs are also 
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capable of converting already differentiated cells into a myogenic fate (Weintraub et al., 
1989; Choi et al., 1990; Miner et al., 1992; Blau, 1992). This "jump" in differentiation 
pathways is surprising, since a differentiated cell is usually considered to be a terminal 
phenotype. Interestingly, there is evidence for such a switch in phenotype during normal 
perinatal development of esophagus muscle, as these cells transdifferentiate from a 
functional smooth type to skeletal muscle by sequentially expressing first the MRFs, and 
then skeletal muscle-specific structural genes (Patapoutian et al., 1995c). This is one the 
few examples of transdifferentiation that occurs during normal development of vertebrates, 
and reinforces the idea that MRFs are powerful regulators, and that evolution has used 
them to their potential. The details, and the significance, of transdifferentiation is further 
discussed in the third chapter of my thesis. 
The Fly Eye and Vertebrate Muscle Development: 
The remarkable similarities between the molecular mechanisms underlying fly 
neurogenesis and vertebrate myogenesis have been discussed previously (Jan and Jan, 
1993). Both systems rely heavily on a family of positive and negative acting HLH 
proteins to specify the individual cell fates. In fly neurogenesis, b-HLH family proneural 
genes [achaete (ac), scute (sc), atonal (ato), etc.] specify neural precursor cells that is 
similar to the role of Myf-5 and MyoD in skeletal muscle determination. Based on more 
recent data from both systems. the parallels between them can now he extended. Similar to 
the subdomains of the myotome that express, and are dependent on. different MRFs; ac 
and sc are initially expressed in, and are required for, different proneural clusters of the 
wing disc. Also similar to the MRFs. while loss-of-function phenotypes of the achaete-
scute (ACS) complex give rise to distinct phenotypes, ectopic expression of any of the four 
ACS complex genes can induce the formation of external sense organ formation, as they 
are able to substitute for one another. 
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More recent studies in the compound eye of Drosophila have confirmed and 
extended the parallels between fly neurogenesis and vertebrate myogenesis. The fly eye is 
composed of 800 ommatidia. The photoreceptors within the ommatidia differentiate as the 
morphogenetic furrow (MF) transverses the eye disc from posterior to anterior during the 
third larval instar. The first photoreceptor to differentiate within an ommatidium is the R8. 
which then initiates an inductive cascade for the formation and differentiation of other 
photoreceptors posterior to the MF. Atonal (ato), a h-HLH protein, functions as a 
proneural gene in the developing tly eye and is required for R8 formation (Jarman et al., 
1994). 
Apart from the molecular similarities, the tly eye is an appropriate developmental 
system to compare to vertebrate myotomal formation because of some morphological 
parallels. Both systems develop through a wave of differentiation that is accompanied by 
changes in cellular morphology that result in repeated structures along the rostrocaudal axis 
(somites and ommatidia) . While R8 is the first photoreceptor to differentiate at the MF and 
is dependent on the b-HLH protein, ato; the first myotomal cells at the dorsomedial lip of 
somites differentiate at a time shortly after somites bud from the pre-segmental plate. and 
are dependent on another b-HLH, Myf-5. Also, while R8 is later required for inductive 
cues that carry out differentiation of other photoreceptors within the ommatidium. the early 
Myf-5-expressing cells are essential for the subsequent formation of secondary myotome, 
as well as rib precursor cells within the somite. 
The expression pattern of HLH molecules with possihle negative functions also 
have striking similarities in fly eye neurogenesis and vertebrate myogenesis. In 
Drosophila, extramacrochaetae (emc) is an HLH protein without a basic domain, similar to 
structure and function to ld-1. Another HLH protein. hairy (h), has a basic domain, hinds 
DNA. hut is a negative regulator of proneural genes. This is reminiscent of m-twist, which 
is also a b-HLH DNA binding protein and can repress the MRFs (Hebrok et al., 1994; 
Yun et al., 1995). All four negative regulators are expressed in cells immediately adjacent 
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to those expressing the positive b-HLHs: Id and m-twist are expressed in early non-
segmented paraxial mesoderm. and later in somitic sclerotomal and dermotomal cells that 
neighbor the MRF containing myotomes (Wolf et al., 1991~ Wang et al .• 1992; Yun et al., 
1995), while in the Drosophila eye ommatidia, emc and hare expressed just anterior to the 
MF and ato expressing cells (Brown et al., 1995). While either h or emc alone are not 
required for normal photoreceptor differentiation, emc_h_ clones in the eye disc cause 
ectopic neurogenic differentiation anterior to the furrow (Brown et al., 1995). This 
suggests that the two negative regulators are partially redundant, and that they jointly 
repress the expression or activity of ato. It would be interesting to see if double mutant 
phenotype of m-twist and Id- I would cause ectopic expression of the MRFs in the mouse. 
According to their expression pattern. and the emc-h- phenotype, the negative regulators in 
both systems might be playing a crucial role to sharpen the boundaries, as well as the 
timing, of the decision to differentiate. The need for multiple negative regulatory proteins 
for the b-HLH driven developmental programs is not clear; however, given their potent 
capacity to dictate cell fate decisions, it is not surprising that a combinatorial negative 
regulation of b-HLH expression and activity is used to secure against inappropriate action 
of these regulators. 
Finally, vertebrate neurogenesis might also he regulated by ACS homologues. 
MASH-I (murine achaete scute homologue) is required for the differentiation of a subset of 
neurons (Guillemot et al., 1993). Another vertebrate family member, NeuroD, when 
ectopically expressed in frog embryos can recruit epidermal cells to a neuronal phenotype 
(Lee et al., 1995). Nautilus, the only MRF homologue found in Drosophila, is expressed 
in a subset of muscle precursors, hut seems to be dispensable for myogenic specification 
(Michelson et al .• 1990). 
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Mechanisms of Cell Type Specification: 
British embryologist Conrad Waddington, writing in 1940, used the image of a ball 
rolling down a landscape through pathways of branching tracks as a useful tool to describe 
developmental progression. and named it the "epigenetic landscape." The landscape in this 
image represents the cellular environment; the hall. as the developing cell; and the tracks, as 
the differentiation pathways. Cells rarely reverse track to an adjacent one. and with time, 
they proceed down the landscape and become more and more distant from each other, 
reflecting different patterns of gene activity. The role of Myf-5 and MyoD appears to be in 
recruiting multipotential cells to a myogenic phenotype, and the role of myogenin is to drive 
the execution of differentiation. This fits nicely in this model of progressive specification. 
"Master regulatory gene" is a phrase that is often used to describe potent regulators 
such as the MRFs. and has come to define a gene that when ectopically expressed in a 
permissive environment can recruit cells to a specific phenotype. Is this a common 
mechanism in Development where each cell or tissue type has its own master control gene? 
It would be rather inefficient for evolution to draw on a separate regulatory gene family as 
lineage-specific differentiation factors for each and individual cell type. It is more 
beneficial to extract specificity by using combinations of regulators to achieve different 
phenotypes. Even most so-called master control genes can only carry out their 
differentiation program under certain conditions, and hence are context dependent. For 
example. eyeless (ey). a homologue of the mouse Small eye (Pax-6) gene, in an ectopic 
expression assay can transform imaginal discs into eye structures and hence is called a 
master control gene. However. it is obviously not sufficient for eye development. since ey 
is also normally expressed in cells that do not form eyes (Halder et al., 1995; Quiring et al., 
1994). The MRFs also may not be entirely restricted to muscle progenitors. In the mouse, 
Myf-5 is transiently expressed in a few neuronal cells during development; however, it is 
now known whether Myf-5 protein is ever synthesized, or if these embryonic cells survive 
to adulthood (Tajbakhsh et al., 1994). Regardless. judged by overall expression pattern, 
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overexpression capacity, and in vivo requirement, MRFs are necessary and, in most 
contexts, sufficient for carrying out skeletal myogenesis. However, the myogenic cell fate 
determination process seems to be an exception rather than the rule, since most decisions of 
cellular specification are under more complex combinatorial and context-dependent control 
of regulatory genes. 
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Summary 
MRF4 (herculin/Myf-6) is one of the four member MyoD family of transcription factors 
identified by their ability to enforce skeletal muscle differentiation upon a wide variety of 
nonmuscle cell types. In this study the mouse germline MRF4 gene was disrupted by 
targeted recombination. Animals homozygous for the MRF4bhl allele, a deletion of the 
functionally essential bHLH domain, displayed defective axial myogenesis and rib pattern 
formation, and they died at birth. Differences in somitogenesis between homozygous 
MRF4bhl embryos and their wildtype littermates provided evidence for three distinct 
myogenic regulatory programs (Myl-My3) in the somite, which correlate temporally and 
spatially with three waves of cellular recruitment to the expanding myotome. The first 
program (Myl), marked initially by Myf-5 expression and followed by myogenin, began 
on schedule in the MRF4bhllbhl embryos at day 8 post coitum (e8). A second program 
(My2) was highly deficient in homozygous mutant MRF4 embryos, and normal expansion 
of the myotome failed. Moreover, expression of downstream muscle specific genes, 
including FGF-6. which is a candidate regulator of inductive interactions, did not occur 
normally. The onset of MyoD expression around el0.5 in wildtype embryos marks a third 
myotomal program (My3), the execution of which was somewhat delayed in MRF4 mutant 
embryos but ultimately led to extensive myogenesis in the trunk. By el5 it appeared to 
have largely compensated for the defective My2 program in MRF4 mutants. Homozygous 
MRF4bhl animals also showed improper rib pattern formation perhaps due to the absence 
of signals from cells expressing the My2 program. Finally, a later and relatively mild 
phenotype was detected in intercostal muscles of newborn animals. 
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Introduction 
In diverse developmental pathways, including skeletal myogenesis in vertebrates, specific 
sets of basic helix-loop-helix (b-HLH) class transcription factors form regulatory networks 
important for cell fate specification and/or terminal differentiation (reviewed by Jan and 
Jan, 1993). In mammals, the MRF (muscle regulatory factor) group includes MyoD, 
myogenin, Myf-5 and MRF4/herculin/Myf-6, (reviewed by Weintraub, 1993) and together 
they compose the core of the myogenic bHLH net. Evidence from several lines of 
investigation have led to the view that these genes are individually and collectively 
important for muscle determination and differentiation. Both in tissue culture cells 
(reviewed by Olson, 1990) and transgenic animals (Hopwood and Gurdon, 1990; Miner et 
al., 1992), dominant gain of function assays have shown that each MRF can activate 
muscle specific genes and, in permissive cell environments, drive wholesale conversion of 
the host cells to a myocyte-like phenotype. At the molecular level, MRFs are sequence 
specific DNA binding proteins that bind to functionally important sites in the enhancers of 
many muscle specific genes (Mum~ et al., 1989; Weintraub et al., 1991). In vivo, MRF 
expression is largely restricted to skeletal muscle precursors and mature myofibers 
(Buckingham, 1992), consistent with functions specific to myogenesis. Finally, germline 
gene disruption experiments in the mouse are now providing stringent in vivo tests of 
inferences from prior expression and molecular studies. So far, these experiments have 
shown that MyoD and My.f-5 are jointly important for formation and/or survival of muscle 
precursor populations (Rudnicki et al., 1993), while myogenin is needed for efficient and 
proper muscle differentiation in vivo (Hasty et al., 1993; Nabeshima et al., 1993). In 
addition to these myogenic phenotypes, null alleles of My.f-5 (Braun et al., 1992) and 
myogenin also affected axial skeletogenesis. disrupting to different degrees distal rib 
formation. Here. we describe disruption of the mouse MRF4 gene. 
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All known skeletal muscle in an adult vertebrate originates from cells of the dorsal 
prechordal and paraxial mesoderm (Wachtler and Christ, 1992). In the trunk and tail 
regions, this multipotential mesoderm is first segmented into somitic blocks in a 
rostrocaudal progression on both sides of the neural tube. Under the influence of signals 
from epidermis, neural tube and notochord, these somites subdivide into dermamyotome 
(muscle and skin precursors) and sclerotome (cartilage and bone precursors), and 
subsequently the dermamyotome further segregates into myotome and dermatome. Within 
the developing dermamyotome and myotome. there is a dynamic pattern of MRF 
expression such that each MRF is expressed in a distinctive spatiotemporal pattern that 
generally overlaps with expression of one or more other family members (reviewed, 
Buckingham, 1992; Smith et al .• 1994). The pattern for MRF4 is different from the others 
in three major respects. First, its myotomal expression occurs in a discrete wave that 
begins at about day 9 post coitum (e9) and ends at around el 1.5. while the others continue 
to be expressed significantly until at least el5 when the axial muscle masses derived from 
the myotome are quite well defined. Second, MRF4 is not involved in early myogenesis in 
the head or limb musculature hut the other three MRFs are. Finally, MRF4 expression 
initiates a second wave at el6 and ultimately comes to dominate quantitatively over the 
other MRFs in adult muscle. an observation that led to the suggestion that MRF4 may be 
needed to maintain the differentiated skeletal phenotype (Miner and Wold, 1990). 
In this work, disruption of the MRF4 gene produced both muscle and skeletal phenotypes 
in the mouse embryo and fetus. Molecular and cytological analysis of homozygous mutant 
MRF4bhl embryos showed that early and late waves of myogenic commitment and 
differentiation in the myotome occurred similarly in mutant and wildtype myotomes, but an 
intermediate myotomal expansion during the period of somitic MRF4 expression (- e9-l l) 
failed. These observations, considered together with patterns of MRF expression and their 
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respective mutant phenotypes, led us to propose a new model for myotome formation in 
which each of three myotomal MRF programs (Myl-My3) drives a distinct wave of 
myotomal cellular expansion. In this model, different combinations of MRFs are required 
for execution of each wave of commitment and differentiation. The effects of the 
MRF4bhl mutation on rib morphogenesis are contrasted with those of mutations in 
myogenin and Myf-5; myotomal cellular domains and specific signaling molecules 
produced from them are considered as candidates for intramyotomal and 
myotome/sclerotome interactions. 
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Materials and Methods 
MRF4 inactivation in ES cells 
The linearized targeting plasmid was electroporated into CJ7 embryonic stem (ES) cells 
followed by selection in the presence of G418 and Gancyclovir. Selection of homologous 
recombination events over other integration sites was facilitated by the presence of two 
HSV-TK expression cassettes, one flanking each segment of MRF4 homology. 423 
independent clones were isolated, and the clones containing a single, correct homologous 
recombination on MRF4 locus were identified by both Southern hybridization and PCR. 
From 23 positive clones, six were selected for injection into mouse blastocysts. Coat 
chimeras ranging from 5% to greater than 90% were generated from six lines, of which 
two were transmitted to the germline. Heterozygous progeny were crossed with C57B6 
mice. Most developmental timepoints assayed in this work were examined in both 
independent lines and no differences in phenotype were detected. 
Genotyping of Progeny. 
Genomic DNA was isolated from either yolk sac or tail biopsies. For Southern 
hybridization, lOµg of DNA was digested with either BamHI and Kpnl restriction 
enzymes, or BamHI and Stul at 37°C. DNA was fractionated on 0.8% agarose gel with 
Tris-Acetate-EDT A buffer, and then transferred to Hybond-N filter with IOXSSPE. Probe 
for hybridization was labeled with [a32P]-dCTP using a random-primed labeling kit 
(Boehringer Mannheim) according to the manufacturer's instruction. Hybridization was 
performed at 680C overnight according to Sambrook et al. (1989). For genomic PCR, 
lµg of DNA was used in 29 cycles with the following three primers: MRF4-forward, 
GGGAGACTGATGCTCCATGACAGC (from MRF4 promoter); MRF4-reverse, 
GTGTTCCTCTCCACTGCTGTCGCT (from MRF4 exon l); POK-reverse, 
GCGCTACCGGTGGATGTGGAATG (from PGK promoter). 
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RNA isolation and RT-PCR 
RNAs were prepared by the method of Chomczynski and Sacchi (1987) from the trunk 
(without limb) region of embryos from different developmental timepoints. Quantitative 
RT-PCR was carried out according to the method of Robinson and Simon (1991). Both 
reverse transcription and PCR were performed in the same tube in a single buffer with 
specific primers. AMV-RT (Promega) was used instead ofMMLV-RT, and Taq antibody 
(Clontech) was also added to block Taq activity at lower temperatures. 22-28 cycles were 
used for different primer sets as shown in Table I. An initial titration was carried out to 
assure that amplifications at high cycle numbers were still in linear range and quantitative 
(AP and BW, manuscript in preparation). All primer sets were designed to span at least 
one intron to distinguish RNA from DNA contamination, and the sizes of the products 
were between 200 and 500 bases. For the el8.5 samples, reverse transcription was carried 
out separately with random hexamer primers (Pharmacia). 
Whole-mount skeletal staining. 
Newborn mice were skinned and eviscerated prior to fixation. Embryos were fixed directly 
in 100% EtOH. After fixation for 3 days, carcasses were incubated in acetone for 3 days. 
Bone and cartilage of mice or embryos were stained for 3 days at :noc with a solution 
containing <HX>5% alizirin red S, 0.015% alcian blue 8GX, 5% acetic acid and 70% EtOH. 
The samples were incubated in 20% glycerol - l % KOH solution for 6hrs at 37oC and then 
kept at room temperature until the skeleton was clearly visible through the surrounding 
tissue. 
Frozen sections and antiboc~v swining 
Embryos were fixed in 4% paraformaldehyde at 4oc overnight. Embryos younger than el 1 
were sunk into 15% sucrose & 7 .5% gelatin in PBS solution and then frozen in OCT 
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(Tissue-Tek). Older embryos were immediately frozen in OCT. Sections of 10-20µm 
thickness were obtained using a cryostat, and were blocked for 20 minutes in 10% goat 
serum and 3% BSA in PBS before applying the primary antibody for 1-3 hours at room 
temperature. The secondary antibody solution was applied for 1 hour. Antibodies against 
myosin heavy chain, (MF20; 1:10 dilution; mouse IgG2b; Developmental Studies 
Hybridoma Bank). striated muscle specific a actinin (1:400 dilution; mouse IgGl; Sigma), 
myogenin (FSD; 1:5 dilution; mouse lgGl; courtesy of W. Wright}, and MyoD (1:10 
dilution; mouse IgGI; Novocastra Lab. Ltd.) were used. Secondary antibodies were 
conjugated to Fluorescein and specific to mouse IgG isotypes and used as 1: 100 dilution in 
3% BSA in PBS (Southern Biotechnology Associates). Images were captured digitally on 
a confocal microscope (BioRad). 
Histology. 
Newborn mice were fixed wit'1 4% paraformaldehyde, dehydrated gradually with EtOH, 
and embedded in paraffin. l 6µm sections were stained with both hematoxylin and eosin. 
Embryos were frozen in OCT after fixation with 4% paraformaldehyde, sectioned at 20µm 
thickness, and stained with both hematoxylin and eosin. 
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Results 
Construction of MRF4bhl mutant mouse strains. 
Two independent strains of mice were generated in which the functionally essential bHLH 
domain of the MRF4 gene was deleted from the chromosome via targeted homologous 
recombination in embryonic stem cells and subsequent transmission into the mouse 
germline. The targeting plasmid was designed to create a null allele of MRF4 by replacing 
codons 40 to 173 of MRF4 (Miner and Wold, 1990) with a PGK-neo selection cassette 
(Fig. la). This eliminates the entire basic-helix-loop-helix domain which is required for 
MRF protein dimerization and DNA binding in biochemical assays (Lassar et al., 1989; 
Lassar et al., 1991) and is also required for myogenic activity in transfection assays 
(Tapscott et al., 1988; Yutzey et al., 1990). We call this the MRF4bhl allele. Blastocyst 
injections produced chimeras from six different targeted embryonic stem cell lines; two 
independent cell lines from different electroporation experiments were ultimately 
established in the germ line. Heterozygous males and females appeared grossly normal and 
were fertile. Genotypes of progeny were determined by Southern hybridization and by 
PCR of DNA from tail or yolk sac. Southern blot analysis showed that the map of the 
targeted locus is as predicted if homologous recombination had occurred between the vector 
and the host chromosome, as indicated (Fig. lB). Additional Southern blot analysis 
showed the related downstream My.f-5 locus to be intact and unaffected (data not shown). 
Progeny from crosses of MRF4hhl heterozygotes harvested during gestation yielded 47 
(29%) wildtype, 85 (53%) heterozygous and 28 (18%) homozygous embryos, results that 
are within 95% confidence limits for 1:2: I Mendelian ratios. Homozygous animals died 
shortly after birth with HK)% penetrance. They showed respiratory distress which may be 
the proximal cause of lethality. 
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MRF4 is an important regulator of early somitogenesis 
Quantitative RT-PCR and immunocytological assays were used to compare littermates of 
wildtype, heterozygous, and homozygous genotypes . The earliest marker of myotomal 
commitment presently known is Myf-5. Previous in-situ hybridizations have shown that 
Myf-5 expression in somites is first detectable at e8, when the first four somites have just 
formed (Buckingham, 1992). The RT-PCR analysis performed here also showed no 
expression of Myf-5 in wildtype e7.5 embryos, but by e8 (6-7 somites) wildtype (data not 
shown), heterozygous, and homozygous MRF4bhl embryos all showed comparable levels 
of Myf-5 expression (Fig. 2A). As expected, the other MRFs were not yet expressed at 
this time in heterozygous or homozygous embryos. Proper Myf-5 initiation argues that the 
MRF4 knockout allele we have constructed does not exert detectable cis-effects on the Myf-
5 gene which is located 7kb downstream (Miner and Wold, 1990). By e9 (13-14 somites) 
myogenin protein expression (Fig. 2b) was detected by immunostaining in heterozygous 
and homozygous MRF4bhl embryos. We conclude that the earliest myotome formation is 
largely unaffected by this MRF4 mutation, and this is consistent with the fact that MRF4 is 
not expressed detectably until after e9 (Bober et al., 1991; Hinterberger et al., 1991; Smith 
et al., 1994). 
The earliest phenotype we detected in MRF4bhl animals was a deficit in myotome 
development that corresponded in time with the first wave of MRF4 expression, beginning 
around e9 and ending around el 1. Quantitative RT-PCR was used to measure expression 
of an expanded set of genes normally expressed in somites at this time. For all studies at 
elO and later, trunk regions were dissected and analyzed without head and limbs. The 
intent was to eliminate interference from MRF4-independent myogenic programs that are 
active in head and limb. By elO, expression of Myf-5, myogenin, and MyoD in the trunk 
were significantly reduced relative to their levels in wildtype littennates (Fig. 3). When 
normalized to GAPDH levels. quantitation of hand intensities showed that Myf-5, 
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myogenin, and MyoD RNA levels in homozygotes were 25%, 8%, and 10% of wildtype 
levels, respectively. Interestingly, MRF4, Myf-5, and MyoD levels were reproducibly 
reduced in the heterozygotes, suggesting that haploinsufficiency in MRF4 is not 
compensated by upregulation of other family members and. moreover, that 
haploinsuffiency in MRF4 radiates through the MRF network to include other members. 
Among downstream muscle specific differentiation genes surveyed, MRF4bhl 
homozygotes showed very substantial deficits, although different genes were affected to 
different extents. For example, FGF-6 and M-Cadherin, genes that are interesting for their 
potential effects on cell-cell interactions, were expressed at markedly reduced but still 
detectable levels (8 and 25 % of wildtype, respectively). However, the effect on the 
embryonic myosin heavy chain (MHC-emb.) was more dramatic, as its RNA appears to be 
entirely absent from mutant embryos at elO, even though in wildtype embryos it has 
accumulated at high levels. Since defects in rib morphogenesis become evident later in 
development and might arise from earlier sclerotomal defects, an array of sclerotomal 
markers including Pax-I. M-Twist, ld-1, Gli-1, and Urokinase were also surveyed. No 
noticeable effects were detected in any of the sclerotomal markers tested (Figure 3). 
In wildtype animals MyoD expression begins gnidually at e9.5 (Smith et al., 1994), and it 
accumulates to significant levels by el 1 (Sassoon et al .• 1989). This is an informative time 
to evaluate the impact of MRF4bhl, because MRF4 is concurrently disappearing from 
wildtype myotomes. At ell, MRF members were still expressed at reduced levels in 
MRF4bhllbhl embryos compared to wildtype. However, the reduction was less dramatic 
than that observed one day earlier. Quantitation of band intensities normalized to GAPDH 
showed Myf-5, myogenin, and MyoD RNA levels in homozygotes were 25%, 21%, and 
32% of wildtype levels, respectively. The picture was similar for muscle specific 
differentiation markers. We conclude that the severe deficit in myotomal myogenesis 
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observed at elO is moderated by el 1, and this was observed in both knockout lines (Fig. 3 
and data not shown). 
An important issue is how the gene expression observed in whole trunk RNA specimens is 
distributed among cells of the developing somite. At one extreme, RNA measurements of 
Figure 3 could retlect differences in levels of gene expression distributed over identical 
cellular domains in the mutant and wildtype; at the other extreme, all RNA could be 
accounted for by changes in the number and/or type of myotomal cells in mutant versus 
wildtype. To help discriminate these possibilities, e 11 wild type and homozygous 
MRF4bhl littermates were sectioned and probed with antibodies to relevant muscle specific 
regulators and structural proteins including myogenin, MyoD, a actinin (Fig. 4), and 
myosin heavy chain (data not shown). The myotomes of mutant animals were greatly 
reduced in size and cell number. Differentiated myocytes could be identified by their 
expression of a actinin (Fig 4A, B, G, H)_ In the homozygotes, these myocytes were 
confined mainly to the dorsal myotomal domain. This was most obvious in caudal 
hindlimb level somites which lag developmentally behind the more mature rostral forelimb 
somites. By el 1, MyoD expression in wildtype and in mutant!\ has begun to accumulate 
(Fig. 4E, F, K. L). At the cellular level. MyoD protein expression outlines a new and 
much larger presumptive myotomal domain in the mutants than that shown for with 
myogenin or a actinin. and the MyoD domain was concentrated more ventrolaterally. 
Axial myogenesis in MRF4bhl homozygotes is grossly normal by e14 
By el4. no MRF4 expression in wildtype embryos can be detected, and it will not 
reappear until about el6. However, the period of myotomal myogenesis coincident with 
the expression of MyoD. which begins around el0.5. has been active for several days. and 
during this time axial muscle mass has expanded significantly. At el4 the RT-PCR 
analysis was again focused on axial musculature. Comparable expression levels were 
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found for most muscle regulators and structural genes tested in wildtype, heterozygous and 
homozygous MRF4bhl fetuses from both knockout strains (Fig. 5 and data not shown). 
Exceptions were Myf-5 and M-Cadherin, both expressed at reproducibly reduced levels in 
mutant animals. At the cellular level, we observed grossly normal muscle mass patterns by 
histological staining of el5 embryos (Fig 6a and b) and by muscle specific antibody 
staining of both limb muscles and intercostal muscles (data not shown). 
MRF4 has subtle effects on intercostal muscles in the newborn. 
To examine the effects of the second wave of MRF4 expression, which starts around e16 
and correlates with the timing of widespread secondary differentiation of muscle, we 
examined RNA from ribcage region of el8.5 and newborn animals by RT-PCR. 
MRF4bhllbhl animals expressed largely normal levels of most muscle specific markers, 
although a modest reduction in My.f-5 and some muscle specific structural genes was 
observed (Fig 5). Similar results were obtained for RNA isolated from limbs (data not 
shown). However, examination of sections from el8.5 and newborn mice revealed that 
some intercostal muscles associated with ribs 3-5 were either disorganized or significantly 
reduced in fiber number in MRF4bhl/bhl animals. This pheontype varied in intensity 
among different homozygous animals, and it remains to be determined whether genetic 
background is playing a significant role. In animals displaying the most intense intercostal 
phenotype, substantial numbers of mononuclear cells were present in homozygous animals 
(Fig 6c and d). Antibody staining for myosin heavy chain (data not shown) and a actinin 
showed that these cells were not differentiated myocytes (Fig 6e and t). This effect on 
myogenesis was not evident prior to the period of fetal MRF4 expression (Fig 6a and b). 
Rib defects in MRF4 null mutant mice. 
Homozygous mice showed obvious respiratory distress and died shortly after birth. Rib 
defects have been observed previously in Myf-5- and myogenin-null mutant mice (Braun 
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et al., 1992; Hasty et al., 1993; Nabeshima et al., 1993). We therefore examined whether 
MRF4-null mutant mice exhibit skeletal abnormalities by staining with alizirin red S and 
alcian blue to detect bone and cartilage, respectively. In newborn mice homozygous for 
MRF4bhl, rib development is severely disturbed (Fig. 7). The abnormalities include rib 
bifurcation, fusion of rib cartilage from adjacent ribs, truncated ribs that fail to attach to the 
sternum, and disorganized ossification in the sternum. Rib foreshortening in ribs 2-12 was 
usually less than 20% of total length, and this led to variable failure to join the sternum. 
Interestingly, the first and last (13th) ribs were more dramatically shortened compared with 
the others. Some ribs also displayed abnormal angles of extension (Fig. 7 g-i). Finally, 
the tuberculum anterior that is normally present on the 6th cervical vertebrae was absent in 
most MRF4bhl/bhl mice (83% penetnmce). Other skeletal elemenL~. including proximal 
regions of ribs and vertebrae appeared to be normal (data not shown). 
To examine when rib defects develop relative to chondrogenesis and ossification, el4 
embryos were stained with both alizirin red S and alcian blue. Normally, rib cartilage 
cytodifferentiation in mice begins at e13, and ossification begins at e14 (Rugh, 1968). In 
all genotypes, the skeleton at d4 was entirely cartilaginous except for the clavicle and the 
earliest ossification centers of facial hones. However, in homozygous MRF4bhl mutants, 
the rib bifurcations and truncated rib forms were already clearly visible (Fig. 7j, k). Thus, 
cytodifferentiation of most rib cartilage occurred at the normal time by this measure, and 
m~jor rib pattern formation defects were clearly visible as soon as chondrogenesis rendered 
rib anlagen histochemically visible. These events occur well before the second period of 
MRF4 expression that begins at e 16. 
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Discussion 
In this study the mouse MRF4 (herculin/Myf-6) gene was disrupted by targeted 
recombination. Animals homozygous for this MRF4bhl allele, which deletes the bHLH 
domain, displayed phenotypic effects on axial myogenesis and on rib pattern fonnation. 
They ultimately died at birth of apparent respiratory insufficiency. A substantial failure in 
myotomal development of homozygous mutants was observed, and it corresponded with 
the early somitic wave of MRF4 expression (e9 to 11). At the molecular level this 
generated a gross but transient deficiency in expression of other MRFs and some muscle 
specific differentiation genes. including FGF-6 and M-Cadherin, which may be important 
in pattern formation and inductive interactions with the sclerotome (see below). The early 
myotomal deficit was largely overcome by subsequent myotomal expansion after the end of 
the MRF4 expression period in the myotome. However, perhaps as a consequence of the 
earlier myotomal phenotype, rib pattern formation was disrupted, and may be the primary 
cause of lethality. A late fetal muscle phenotype was also detected in some intercostal 
muscles of newborn mice, suggesting a possible effect from the lack of MRF4 expression 
that nonnally begins in muscles at el6; this might also contribute to lethality in the mutants. 
MRF4bhl reveals three waves of myotomal expansion, each dependent on a 
different set of MRFs 
A striking aspect of myotome formation in MRF4bhl homozygotes was the observation 
that an entire cellular myotomal domain appeared to be missing. Comparison of mutant and 
wildtype embryos before, during and after the window of MRF4 somitic expression leads 
us to propose the model shown in Figure 8 for myotome biogenesis in the mouse. It 
identifies three different myotomal MRF programs (Myl, My2 and My3) with three waves 
of myotomal cellular commitment and differentiation that result in production at the cellular 
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level of primary. secondary, and tertiary myotomes. This nomenclature refers to different 
spatiotemporal phases of myotome formation. and should not be confused with primary 
and secondary myocytes that refer to embryonic and fetal myogenic differentiation, 
respectively. The My 1 program is first and begins at e8; it uses Myf-5 and myogenin. By 
e9, this program has produced differentiated myocytes that are expressing myogenin and 
structural markers such as cardiac and skeletal ex actin (Buckingham, 1992) in a small 
domain that typically includes less than 20 cells per somite at the future forelimb level. 
These cells are concentrated dorsally in the somite. The expression of Myf-5 protein in a 
domain of this size and position was recently described in a detailed study by Smith and 
Miller (Smith et al .• 1994). Previous studies of a Myf-5 gene disruption (Myf-sml) 
(Braun et al., 1992; Braun et al., 1994) have shown that there is no detectable myocyte 
differentiation in My.f-5 deficient homozygotes until el0.5. This suggests that My.f-5 
function is essential for the My l program, and is consistent with expression patterns. 
Whether myogenin is also essential for execution of this MRF program is not certain, as 
phenotypic data is not yet available for myogenin null mutants at the early times (Hasty et 
al., 1993; Nabeshima et al., 1993). The Myl program is initiated on schedule by both 
molecular and cellular assays, in the MRF4bhl homozygotes (Figure 2). 
The phenotype of MRF4bhl homozygotes suggests the existence of a second MRF 
program (My2) that is needed to execute a new wave of myogenic recruitment in the 
myotome. This myotomal expansion normally occurs during the period of MRF4 
expression beginning at about e9 in rostral somites, and involves an increase of at least 15-
fold in the number of cells expressing myogenin or other skeletal muscle markers (Smith et 
al., 1994). The most straightforward interpretation of data from our MRF4 gene 
disruption is that the proposed secondary wave of myotomal expansion requires MRF4 
function. Myf-5 is also required, because Myf-5ml homozygotes form neither the 
proposed primary or secondary myotomes, nor do they turn on MRF4 or other muscle 
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specific genes during this time (Braun et al., 1994). It is not clear, however, whether the 
dependence of secondary myotome fonnation on Myf-5 is cell autonomous or not. Thus in 
one scenario, Myf-5 expressing myoblasts within the primary myotome would migrate, 
change their MRF expression pattern (including initiation of MRF4 expression) and then 
form the secondary myotome. In a nonautonomous mechanism, mesodermal precursor 
cells neighboring the primary myotome could be directly induced to express MRF4 and 
myogenin and thus commence fonnation of the secondary myotome. In either case, MyoD 
is not widely expressed until later times, and does not significantly compensate. It is 
interesting that myogenin null embryos apparently show normal somitic and myotomal 
morphology during the My2 program. and it will now be useful to examine muscle specific 
gene expression between e8.5 and e 10.5 in myogenin knockout mice to see whether the 
secondary wave of muscle differentiation proposed here occurs normally. 
The proposed My3 program is marked by the onset of MyoD expression, and prominent 
myogenin expression. Together, they appear sufficient to direct a third m~ior cellular 
expansion that produces the tertiary myotome of Figure 8 between el 1.5 and 15. Thus, in 
Myf-Sml null embryos, there is no detectable myotome formation until the onset of MyoD 
expression around el0.5. hut that following onset of its expression a large myotome 
quickly forms, and subsequent axial myogenesis appears surprisingly normal (Braun et al .• 
1994). This led those investigators to propose the regulatory and functional independence 
of a MyoD driven myotome. and data presented here lead us to identify it as the third of 
three waves of myogenesis in the mouse myotome. MRF4 is not detectably expressed 
during most of the My3 period, nor is there any evidence that it can he accessed to 
compensate for MyoD when MyoD has been mutated (Rudnicki et al., 1992). However, 
in the MRF4bhl homozygotes, the timing of the MyoD dependent myotome expansion was 
somewhat delayed. suggesting the possibility of positive inductive interaction between My2 
and My3. Myf-5 expression normally declines between ell and 16, and its domain of 
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expression does not appear to fully overlap the expanded area in which MyoD and 
myogenin are prominent (Smith et al., 1994). However, in MyoD knockout mice, Myf-5 
appears to compensate (Rudnicki et al., 1992); it is expressed at relatively elevated levels in 
these animals for an extended period. They ultimately appear to have normal axial 
musculature. This is one of several situations in which it is unclear whether compensation 
is at the level of cells or at the level of MRF molecules. Thus, compensation might 
represent the expansion of a pool of cells that express Myf-5 and myogenin or might 
instead reflect crosstalk among MyoD family regulators within a cell. 
Rib pattern formation phenotypes in MRF4bhl/bhl mice. 
The rib morphogenesis phenotypes in the MRF4bhl homozygotes are quite different from 
those of the Myf-sml homozygotes and are more similar to the myogenin null rib defects. 
The Myf-5 mutant has only rudimentary rib stumps at all vertebrae, but the MRF4bhl 
homozygotes have extensive rib formation that is mainly disrupted at distal locations close 
to the sternum. This argues that the basis for the pattern formation disturbances in these 
animals are mainly interactions between myotome and sclerotome that depend on cells and 
signals produced in the My2 myotome of the model. while the more dramatic reduction in 
rib formation found in the My.f-5 mutant might he attributable to failure of the Myl 
program. Christ and colleagues (Huang et al., 1994) have recently reported that in the 
chick-quail system, cells from the somitocoele of early epithelial somites are rib 
progenitors. Moreover, homotypic somitic transplantation experiments revealed that rib 
progenitors from one somite can later be found in two ribs, the somite transplanted and the 
next most rostral rib. At slightly later developmental times. cytological studies have noted 
the close apposition of lateral sclerotomal cells with the emerging myotome. It is 
interesting to speculate that cells of the secondary (and perhaps primary) myotome of 
Figure 8 provide signals and cellular scaffolding as these cells elongate in the rostral caudal 
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axis; and if these signals or cellular scaffolding are underdeveloped, migration of rib 
progenitors may be obstructed, and later reflected as the bifurcations and spurs (Fig. 4). 
A candidate signaling molecule that could mediate inductive interactions within the 
expanding myotome or between myotome and sclerotome was suggested by results 
presented here. FGF-6 is specifically expressed in myotomes starting at e9.5, about the 
same time that MRF4 starts to accumulate (Han and Martin, 1993; deLapeyriere et al., 
1993). FGF-6 belongs to the family of fibroblast growth factors, and here we 
demonstrate that its levels are strongly downregulated in myotomes of MRF4 null mice 
(8% of wildtype). Although the specific functions of FGF-6 are not presently known, it is 
an attractive candidate for intercellular signaling between cells of the myotome and the pool 
of proliferating precursors that are being recruited to the expanding myotome throughout its 
maturation. A second plausible interaction is with adjacent sclerotomal cells that are 
thought to include rib progenitors. Therefore, it is potentially relevant that FGF family 
receptors such as FGFR-1 and FGFR-2 are expressed in sclerotomal cells (Peters et al., 
1992; Yamaguchi et al., 1992), but no known candidate ligands have been identified within 
the sclerotome itself. This raises the possibility that FGF-6 secreted from myotomes might 
act as the ligand for these receptors. The possibility of involvement of the FGF family in 
rib development is also suggested by recent findings of several inherited human skeletal 
disorders that correlate with mutations in FGF receptors, including FGFRl and 2 
(reviewed by Eriebacher et al., 1995). 
The skeletal and myogenic phenotypes of MRF4bhl lbhl mice resemble phenotypes of 
mutations in two genes involved in cdl-cell inductive interactions. Follistatin interacts with 
activin/inhibin. and modulates its function (reviewed by DePaolo et al., 1991). In 
follistatin null mutant mice the 13th rib is absent and, in some genetic backgrounds, the 7th 
rib fails to attach to the sternum (Matzuk et al., 1995). In addition, intercostal muscles of 
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newborn follistatin null mice showed sparse and somewhat disorganized muscle fibers, 
similar to MRF4 null mice. The expression pattern of follistatin is also suggestive. It 
appears in somites prior to MRF4 expression (Albano et al.. 1994; Feijen et al., 1994), 
opening the possibility that it acts upstream of MRF4; it will he informative to study how 
MRF4 and Myf-5 are expressed in somites of follistatin null mice. BMP5 is one of the 
large family of hone morphogenetic factors related to TGF~. In BMP5 null mice, the 13th 
rib and the tuherculum anterior of the sixth cervical vertebra are absent (Kingsley et al .• 
1992), two features also found in MRF4hhllbhl animals. BMP5 is expressed widely in 
skeletal precursors (King et al., 1994 ). and it remains to be determined whether its 
expression is altered in MRF4 null mutants. 
Myf-5 and MRF4 are located only 7kh apart on the chromosome (Miner and Wold, 1990), 
while myogenin and MyoD are unlinked. This raises the possibility that changes at the 
MRF4 locus, which in this study included deletion of protein coding and first intron 
sequences as well as insertion of a neo selection cassette, might exert effects on Myf-5 in 
cis. A recent study by Arnold and colleagues provides evidence for such complex cis 
interactions (Braun and Arnold, 1995). They found that a disruption designed to remove a 
segment of MRF4 that is entirely upstream (5') of that deleted in MRF4bhl allele 
unexpectedly eliminated virtually all My.f-5 expression and function. This led to a 
phenocopy of the Myf-Smllml rib and myotome defects. It is clear that early Myf-5 
expression, which defines the start of the My 1 program in our model. was 
indistinguishable from wildtype in the MRF4bhl disruption (Figure 2). Moreover, the bbl 
rib defects were clearly not a phenocopy of the more extreme Myf-5 deficiency. In 
addition, we observe significant expression of My.f-5 at later developmental times, which 
further distinguishes it from the allele of Braun and Arnold (1995). We conclude that the 
MRF4bhl allele does not generate a wholesale cis disruption of Myf-5 expression. 
However, cis effect~ could he a part of the myotomal MRF4bhl/bhl phenotype, if such cis 
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effects operate on a specific subset of Myf-5 expression that mainly overlaps 
spatiotemporally with MRF4 expression in the wildtype. Such cis effects on Myf-5 could 
also explain the RT-PCR data from el4 embryo trunks where, unlike MyoD and 
myogenin, Myf-5 expression remains at lower levels in MRF4bhl/bhl embryos than in 
wildtype. However, this remains only one interpretation, as at this late embryonic stage, 
Myf-5 expression in wildtype is dropping relative to other MRFs and may therefore simply 
not play a significant part in the MyoD directed My3 program. A third MRF4 allele has 
been generated concurrently with these (Zhang et al, 1995). This allele removed a larger 
segment of protein coding sequence than in the bhl allele. including some 3' flanking 
sequences, and it also left a PGK-neo cassette behind, though in different orientation. It 
displayed a rib phenotype similar in pattern formation character to MRF4bhllbhl but with a 
far milder effect at the point of joining to the sternum. Apparently owing to the milder rib 
phenotype, homozygotes of this mutation were viable and this permitted studies of adult 
muscle where a five-fold relative upregulation of myogenin RNA was observed, 
suggesting compensation for the deficit in MRF4. It will now be interesting to compare 
early somitic myogenesis in the two alleles prior to el 1.5. Also, given the uncertainties 
attached to both positive and negative regulatory influences originating from the selection 
cassette enhancer/promoter residue present in all three MRF4 mutations and in the Myf-
5m I allele, analysis of this locus will benefit from new methods that allow for nearly 
complete excision of targeting vector residue (reviewed by Sauer 1993). 
Additional questions concerning the lineage, fate, and function of cells of the embryonic 
myotome are raised by our results. With respect to the fate of cells from the 1 o or 20 
myotome in later development, no cell tracing experiments have yet been reported that 
could tell us how long they live, whether they expand their domain, nor where these cells 
might be located in the mature musculature. The cells appear to be mainly mononucleate 
myocytes and, by their cell number alone, they cannot make a major contribution to the 
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mature axial musculature. The observation that rib defects occur in knockouts of any of the 
three MRFs that are expressed in the primary or secondary myotomes, together with the 
capacity of the tertiary myotome to compensate for lack of the previous two in later muscle 
formation, suggests that the early myotome may be mainly important as an inductive 
regulator and pattern formation guide for rib anlagen. 
In a broader context, analysis of the MRF4bhl mutant underscores the dynamic quality of 
the somite. We have proposed that different combinations of MyoD family genes are 
needed to support distinct waves of cellular commitment and muscle differentiation, but 
why is the myotome built up in this apparently piecemeal fashion? One reason could be to 
limit muscle differentiation to specific subsets of precursors at early times, while others in 
the same signaling microenvironment are permitted to proliferate further. Also, at different 
times in the growth and maturation of the myotome, the sources of inductive and inhibitory 
interactions driving muscle determination and differentiation such as neural tube. 
sclerotome. earlier myotome or dermatome are themselves changing rapidly and are likely 
to be expressing different signals. Thus the multiplicity of MRFs may be most important, 
at least in the embryo, because they provide for myogenic responses to separate signaling 
pathways. The complexity and developmental diversity of cis regulatory elements currently 
being identified in MRF genes provides indirect support for this view (Patapoutian et al., 
1993; Cheng et al., 1993; Yee and Rigby, 1993; Goldhammer et al. 1995), while direct 
tests may require gene transplacement experiments in which one MRF protein coding 
sequence replaces another in the mouse germline. 
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Table I: Primers used in RT-PCR. 
Gene Forward Primer Reverse Primer Cycle# 
MRF4 CTACA1TGAGCGTCTACAGGACC CTGAAGACTGCTGGAGGCTG 27 
Myf-5 TGAATGTAACAGCCCTGTCTGGTC CGTGATAGATAAGTCTGGAGCTGG 26 
Myooa AGGCTCTGCTGCGCGACC TGCAGTCGATCTCTCAAAGCACC 26 
myogenina GAGCGCGATCTCCGCTACAGAGG CTGGCTTGTGGCAGCCCAGG 28 
FGF6 GTGCTCTCTTCA1TGCCATGAACAG CCCCGTGAGCC1TCATCC 28 
MEF2DC CAAGCTGTTCCAGTATGCCAG AAGGGATGATGTCACCAGGG 26 
M-cadherin CAGGTTCACCATCC1TGAAGGT TGGGTCGTAGTCTTTGGAGTAGC 26 
ACHR-y CAGCGCAATGGATTAGTGCAGG GTCAGGCACTTGGTTGTAGTGGG 27 
NCAM(MSD) TCCTCCACAGGCTCCTGCTAAC CGCTCTGTACTTGACCAGATAGTG 26 
MLCIF AAAGACGTGAAGAAGCCCGCTG ATAACCTCCCTGGTCCTTGTfG 23 
a skeletal actin Tf ATCGGTATGGAGTCTGCGGG CACAGCACGA1TGTCGATfGTGG 22 U'I ..... 
MCK TTCGGCAACACCCACAACAAGTTC ACATAGTTGGGGTCCAGGTCGTC 22 
MHC-embryonic GCAAAGACCCGTGACTTCACCTCTAG GCATGTGGAAAAGTGATACGTGG 23 
MHC-perinatal GAAGACCGCAAGAATGTGCTCC CCTCCTGTGCTTTCCTTCAGCC 22 
PAX-IC CACATTCAGTCAGCAACATCCTG TGTATACTCCCTGCTGGTfGGAA 25 
M-1WIST AGCGGGTCATGGCTAACGTGCGGGA GGAGCCGGTCCTTACCTAGG 26 
ID-I CTGGAGCTGAACTCGGAGTCTG CTGAAAGGTGGAGAGGGTGAGG 23 
Glid CTGATITCAGGGAAGAGAGCAGACTGA ACAAGCTTATGCAGCTGATCCAGCCTA 26 
Urokinase GTCTGTAGACCAACAAGGCTTCC GGATTATAGGAGCTCTCCTTCGAC 27 
GAPDH GTGGCAAAGTGGAGATTGTTGCC GATGATGACCCGTITGGCTCC 22 
a Hannon et al. 1992; bMartin et al. 1994; Cfan and Tessier-Lavigne, 1994; dwalterhouse et al. 1993 . 
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Figure 1. Targeted disruption of the MRF4 locus by homologous recombination. 
(A) Structure of the wildtype and mutated MRF4 loci. For the targeting vector, the Kpnl-
Stul fragment of the MRF4 gene, which contains all coding sequences for the basic HLH 
domain. was replaced with a PGK-neo cassette for positive selection in G418. HSV-tk 
cassettes flanked the targeting vector's homologous sequences to maximize the efficiency 
of negative selection with gancyclovir. Direction of arrows in the targeting vector 
represents the direction of transcription units. Exons of MRF4 and Myf-5 genes are shown 
as black and gray rectangles, respectively. The tr-clllscriptional direction of both MRF4 and 
Myf-5 genes is from left to right. Abbreviations for restriction enzymes are B, BamHI; E, 
EcoRI; K, Kpnl; and S, Stul. Restriction enzyme sites in parentheses were lost in the 
cloning process. 
(B) Southern hybridization of genomic DNA. Genomic DNA isolated from tail was 
digested with BamHI and Stul, fractionated on a 0.8% agarose gel, and transferred to 
Hybond-N. Using probe A (see panel A), 2.3kb and 3.8 kb bands that represent wildtype 
and mutated MRF4 alleles, respectively. were detected. 
(C) Genomic DNA PCR. DNA was amplified with locus specific primers (see materials 
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Figure 2. Expression of MRFs in mice lacking MRF4 during initial myotome formation. 
(A) Quantitative RT-PCR on MRF4bhl homozygote and control littermates from whole e8 
embryos. 6-7 somite stage homozygote and heterozygote animals show comparable Myf-5 
and control GAPDH levels and no detectable myogenin and MRF4 expression (*). 
(B) Transverse sections of heterozygote and homozygote e9 (13 somite) embryos showing 














Figure 3. Early MRF4 expression is required for muscle specific gene expression in 
myotomes. 
Quantitative RT-PCR on MRF4bhl homozygote and control littermates from elO and el 1 
trunk (without head and limb) embryos with muscle specific and other non myotomal 
somitic genes. At elO all muscle specific genes examined are expressed at lower levels in 
homozygous animals. Heterozygous animals also show some downregulation compared to 
wildtype littennates. Non-myotomal somitic genes and control GAPDH are expressed at 
normal levels in MRF4 knockouts. At el 1, muscle specific genes are still expressed at 
reduced levels in MRF4 knockouts, however, the downregulation of some genes, such as 
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Figure 4. Effects of MRF4 knockout on myotomal domains at el 1. 
Transverse sections of wildtype and MRF4bhl homozygous ell littermates stained with 
antibodies against a actinin (A, B, G, H), myogenin (C, D, I, J), and MyoD (E, F, K, L). 
All panels show dorsal region of transverse sections. The ventral side of embryo is facing 
downwards, and the neural tube is on the upper left hand comer. Forelimb level somites 
(A-F) represent more mature myotomes than do hindlimb level somites (G-L). The 
number of cells expressing muscle specific markers is strongly reduced in homozygote 
animals. a actinin expression in both forelimb (A. B) and hindlimb (G, H) level 
myotomes is reduced to the dorsal, earlier forming myogenic cells in MRF4 knockouts. 
Myogenin expression in the younger hindlimb level somites (I, J) is restricted to a few cells 
of the dorsal myotome in the MRF4bhl/bhl animals. In the forelimb region (C, D), 
myogenin expression in the MRF4 knockout starts expanding ventrally; however, it is still 
in a very restricted region compared to the wildtype littermate. MyoD expression (E, F, K, 
L) is the least affected in homozygous animals. Although fewer cells express MyoD in the 
myotomal region of MRF4bhllbhl animals, the domains of expression are comparable in 
wildtype and homozygote animals at both limb levels. 







Figure 5. Expression of muscle specific genes in mice lacking MRF4 during late 
embryogenesis. 
Quantitative RT-PCR on MRF4 knockout and control littermates from el4 and el8.5 
embryos. RNA was isolated from ribcage region of animals, avoiding internal organs such 
as heart. At both timepoints, most muscle specific genes and control GAPDH show 
normal levels of expression in homozygote animals. Myf-5 levels are lower in 
MRF4bhl/bhl mice , and no MRF4 expression is observed. M-Cadherin is 
downregulated in homozygote animals at el4, while MLCJ F and MHC-embryonic are 
slightly downregulated at e18.5. 
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Figure 6. Abnormal intercostal muscle formation at el8.5 and newborn in MRF4bhVbhl 
mice. 
Frozen sections of el5.0 day embryos (A and B) or sections of paraffin embedded 
newborn mice (C and D) were stained with hematoxylin/eosin. Unlike the wildtype mice 
(C). disorganized muscle fibers and an increased number of mononuclear cells are seen in 
intercostal muscle of newborn MRF4bhVbhl mice (D). However, intercostal muscle looks 
similar in both wildtype (A) and MRF4bhVbhl (B) embryos at el5. Immunostaining of 
intercostal muscles with a actinin antibody shows MRF4bhVbhl mice (F) have abnormal 













Figure 7. Skeletal defects in MRF4bhllbhl mice. 
Skeletons of wildtype and MRF4bhllbhl mice were stained with alizirin red S and alcian 
blue. (A and B) Ventral view of thoracic region of wildtype (A) and MRF4bhllbhl (B) 
newborn mice. While the first seven ribs are attached to the sternum in wildtype mice. only 
few ribs are connected in MRF4bhllbhl. Anomaly of xiphoid process and severe 
truncation of first rib is also seen in MRF4bhllbhl mice (arrows). (C and D) Ventral view 
of lower thoracic vertebrae of newborn mice. Unlike wildtype (C). the 13th rib appears as 
an anlage in MRF4hhllbhl (D, arrow). (E and F) Lateral view of cervical vertebrae of 
newborn mice. In MRF4bhllbhl (F). the tuberculum anterior on the 6th cervical vertebra is 
missing, and a very truncated first rib is observed (arrows). (G-1) Lateral view of thoracic 
region of newborn MRF4bhl/bhl mice. MRF4hhl/bhl skeletons show a bifurcation, a 
fusion, and abnormal angle of rib extension (arrows). (J and K) Lateral view of thoracic 
region of el4.0 day embryo. Rib defect is already obvious at e14 day of MRF4hhl/bhl 
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Figure 8. A summary model is proposed for myotome formation in the mouse and the role 
of MRF regulators in the process. It is based on the molecular and histological phenotypes 
of the various MRF knockouts and on the expression patterns of the MRFs according to 
previous in-situ hybridizations studies and immunohistochemical staining (reviewed, 
Buckingham, 1992; Smith et al .• 1994). See the discussion for details and explanation. 
Model for MRF Regulatory Programs in Myotome Biogenesis 
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Abstract 
Transdifferentiation is a relatively rare phenomenon in which cells of one differentiated type 
and function switch to a second discrete identity. Smooth muscle and skeletal muscle are 
distinct tissues that arise in vertebrate embryos via separate developmental pathways. We 
found that the musculature of the mouse esophagus is exceptional because it begins as 
smooth muscle in the fetus but later undergoes a conversion to skeletal muscle during early 
postnatal development. Surprisingly, the switch from smooth to skeletal muscle features 
the transitory appearance of individual cells expressing both phenotypes, suggesting that 
this conversion occurs by programmed transdifferentiation. 
Text 
Skeletal and smooth muscles of vertebrates are distinct tissues that differ with respect to 
structure, innervation, and function (J). For example, at the cellular level, skeletal muscle 
is composed of fused multinucleate myotubes containing striated fibers, while smooth 
muscle is composed entirely of mononucleate, nonstriated cells. At the molecular level, 
these differences arise from selective expression of genes specific for each muscle type. 
For example, the MyoD family of myogenic regulatory factors (MRFs: MyoD, myogenin, 
Myf-5 and MRF4) are transcription factors required for the formation and proper 
differentiation of skeletal muscle in vertebrates and their expression is specific to the 
skeletal muscle lineage (2). 
The musculature of the mammalian stomach and intestine is composed exclusively of 
smooth muscle type, but the esophagus differs because it also contains skeletal muscle. 
While the developmental origin of esophageal skeletal muscle has not been studied 
previously, all known vertebrate skeletal muscles are derived from dorsal prechordal and 
paraxial mesodenn, and smooth muscles of the gut are thought to arise from lateral 
splanchnic mesodenn. During embryogenesis, these mesodennal anlagen are separated 
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from each other long before the first smooth or skeletal muscle cells are specified or 
differentiated. 
By monitoring the expression of genes specific for smooth or skeletal muscle, we found 
that during early development, mouse esophageal musculature consists of solely 
differentiated, functional smooth muscle. Subsequently, esophageal expression of smooth 
muscle genes declines and is replaced by skeletal muscle-specific genes. This transition 
from smooth to skeletal muscle types occurred in a rostrocaudal progression beginning in 
late fetal development and continuing through the first two weeks of postnatal 
development. Antibodies to skelecal fast myosin heavy chain (MHC) and smooth myosin 
light chain kinase (MLCK) were selected for this study, since these markers were entirely 
specific for their respective tissue types: skeletal MHC began to be expressed in myotomes 
at embryonic day 9.5 (E9.5), while smooth MLCK was first detected in visceral smooth 
muscle scarting at El2.5 (3, 4). Transverse sections through diaphragm-level (mid-
esophagus) mouse embryos from several developmental timepoints were double labeled 
with these antibodies. The muscularis layer initially stained for only smooth MLCK at EIS 
(Fig. IA) and at PO (newborn) (Fig lB), but by postnatal day 3 (P3) it expressed both 
skeletal and smooth muscle proteins (Fig. IC). Surprisingly, higher magnification 
revealed co-expression of both smooth MLCK and skeletal MHC in the cytoplasm of 
individual cells (Fig. ID). At P7 (Fig. IE), smooth MLCK began to be downregulated, 
and by P14 (Fig. lF). and adult (3), the muscularis layer of esophagus had completely 
switched to expressing the skeletal muscle marker only. As expected, the muscularis 
mucosae (the inner thin layer of muscle in the esophagus) expressed only smooth MLCK at 
all times, while the nearby diaphragm exclusively expressed skeletal MHC. Feeding, 
which requires esophageal peristalsis, begins immediately following birth; and since only 
smooth MLCK is expressed at this level in the newborn esophagus muscularis, we 
conclude that smooth muscle is functionally sufficient for nursing. Smooth muscle myosin 
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heavy chain, another smooth muscle-specific gene, was also expressed in the esophageal 
musculature at prenatal timepoints, confirming the smooth muscle phenotype of these cells 
(5) . Using the same antibodies, we also found that the transition from smooth to skeletal 
muscle in esophagus occurred in a rostrocaudal wave, such that the upper esophagus 
acquired a skeletal phenotype earlier than the lower esophagus (Fig l, G and H) (3). 
Expression of another skeletal muscle-specific protein, alpha actinin, showed the same 
pattern as skeletal MHC for all developmental timepoints (3). 
The unanticipated co-expression of smooth and skeletal differentiation markers within 
individual cells was observed from El6 (rostral sections) to P8 (caudal sections) (Fig ID) 
(3). To confirm the co-expression, P3 esophagus tissue was partially dissociated to yield 
single-cell smears. This permitted us to visualize single cells and confirmed co-expression 
of markers within single cells (Fig. 1, I to L). The overall developmental progression from 
smooth to skeletal tissue types, together with co-expression of smooth and skeletal markers 
in individual cells, suggests that functional, differentiated smooth muscle cells are 
switching directly to differentiated skeletal myocytes. The presence of syncytial myofibers 
in the esophageal dissociation preparations provided additional cytological evidence for the 
skeletal character of the final muscle phenotype (3). 
The expression of the MRFs is specific to skeletal muscle and its progenitors, and at least 
one of the MRFs is expressed prior to transcription of any muscle-specific structural gene 
(6). The pattern and timing of MRF expression in the esophagus is relevant to the 
phenotypic switch, since the expression of MyoD family regulators mark commitment to 
skeletal muscle phenotype. At El5 (Fig. 2, A and B) and at birth (3), diaphragm-level 
esophageal musculature did not stain with MyoD or myogenin antibodies, while smooth 
muscle-specific MLCK was highly expressed. In situ hyhridiz.ation studies also showed 
that Myf-5 and MRF4 RNA were not expressed in the muscularis layer of diaphragm-level 
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esophagus at El5 (3). Shortly after hirth, the diaphragm-level esophageal musculature 
expressed myogenin (Fig. 2C) and MyoD (3) as well as MLCK. Single-cell resolution 
microscopy showed that nuclear myogenin was co-localized within the same cells that 
expressed cytoplasmic smooth MLCK (Fig. 2D). and this was verified by examination of 
dissociated esophagus tissue (3). We conclude that expression of smooth muscle 
differentiation genes precedes the expression of all four MRFs, and this supports the idea 
that esophagus begins as differentiated smooth muscle before it commits to a skeletal 
muscle phenotype. 
The mixed cell phenotype suggesLi; that the tissue-level conversion from smooth to skeletal 
muscle occurs by transdifferentiation. However, only a small percentage of cells expressed 
this mixed phenotype at any given time. While this would he expected if the transition is 
quite rapid, it also raised an interesting alternative to direct conversion: the switching cells 
are fated to die or, give rise to a minor population of the mature skeletal muscle, while the 
main body of skeletal muscle will come from a population of precursor cells that had never 
assumed a smooth muscle phenotype. Initial attempti; to discriminate between these 
possibilities hy marking individual smooth muscle cells of the early esophagus to trace their 
fate at later times failed due to inaccessibility of the esophagus to surgical manipulation. 
However. at various rostrocaudal levels and developmental timepoints, apoptosis was 
assayed by propidium idodide staining. No pronounced cell death was observed in the 
esophageal tissue. Of the rare pyknotic nuclei found, many were observed in the stratified 
squamous epithelium, a non-muscle tissue. The few cells in the muscularis layer of 
esophagus that stained strongly with propidium idodide did not express skeletal MHC or 
smooth MLCK, arguing against massive cell death in the muscle cells of esophagus at this 
time (Fig. 3, A and B) (3). Furthermore, 5-hromo-2'-deoxyuridine (BrdU) labeling of 
El8 and PS animals showed only a moderate level of dividing cells in the muscularis layer 
of esophagus, and most of the dividing cells were in the smooth muscle population (Fig 3, 
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C to F) (3), arguing against the presence of a m~jor population of skeletal-muscle precursor 
cells that could repopulate the muscularis layer of esophagus. Taken together, these data 
suggest a model in which skeletal muscle in esophagus derives mainly from smooth 
muscle. and are consistent with direct transdifferentiation as the principle mechanism of 
conversion. 
Transdifferentiation is thought to he a relatively rare phenomenon, and most known 
examples in vertehrates differ in suhstantial ways from the smooth to skeletal muscle 
transition in the mouse esophagus (7). First. prominent examples such as amphihian limb 
regeneration and chick retina regeneration occur in response to injury (8, 9), while 
conversion of neural crest derived adrenal chromaffin cells into sympathetic neurons occurs 
under experimental manipulations (JO, 11). In contrast, the esophageal smooth to skeletal 
muscle conversion is part of the normal developmental program. Other cases typically 
involve a discrete "dedifferentiation" step in which the initial differentiated phenotype is 
downregulated, a relatively undifferentiated intermediate is estahlished, and finally 
differentiation to an alternative "terminal" phenotype is executed. In this work, we 
observed coincident expression of genes that define the two terminal phenotypes involved, 
suggesting a direct switch without passage through an intermediate. However, the 
transdifferentiation in esophagus is not the only example of a direct phenotypic switch 
during unperturbed vertebrate development; Sympathetic neurons that innervate sweat 
glands undergo a perinatal change in neurotransmitter phenotype from noradrenergic to 
cholinergic (12). 
A major theme in vertebrate development is that differentiated cells of mature, functioning 
tissues arrive at their respective identities via a series of stepwise changes in cellular 
phenotype. These changes lead from relatively unspecified progenitor cells of wide 
developmental potential to increasingly specified cells of limited potential, a pathway that 
82 
retlects sequential changes in the repertoire of genes expressed at each step. The perceived 
universality of such developmental progressions makes an apparent "jump" from the end 
product of one pathway directly to the end product of a different pathway a surprising 
phenomenon, and immediately raises questions ahout the underlying mechanism. The 
regulatory properties of the MyoD family skeletal muscle regulators (MRFs) suggest a 
candidate mechanism. Experimentally induced ectopic expression of the MRFs can 
dominantly co-opt various tenninally differentiated cells (including primary smooth muscle 
cells in culture) to a skeletal muscle phenotype (13, 14, 15, 16). In the esophageal muscle 
pathway, evolution may have capitalized on the potential of MRFs to drive a direct 
transition to skeletal muscle. And hecause smooth and skeletal muscle share a general 
contractile function, a direct shift from one to the other that preserves function during the 
transition might he an attractive option. In support of this idea, there is a second candidate 
case for a muscle conversion in the avian eye. In mammals, the iris muscles of the eye are 
entirely smooth in type, hut in the chick they are of skeletal type and there is evidence that 
they express smooth muscle specific genes as a transition state to a mature skeletal muscle. 
This transition occurs hefore hirth and eye function, and it is not clear whether the starting 
point is functional smooth muscle (17). There is presently no information on MRF 
expression in the chick iris muscle, hut if the process is similar to that in the esophagus, we 
would expect the MRFs to he involved. 
This initial characterization of a smooth to skeletal transition and it~ relationship to current 
knowledge of molecular and developmental determinants of myogenesis leaves many 
questions unanswered. While activation of MyoD family regulators may drive the 
transition, it is unclear what triggers them to be expressed or what events lead to the down-
regulation of smooth muscle genes are unclear. Similarly, the origin and nature of the 
inductive interactions that regulate the slow rostrocaudal wave of skeletal differentiation are 
unknown, though one attractive explanation would he an initial induction, followed by new 
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conversion of more caudal cells by contact with more rostral skeletal muscle. The origin of 
muscle cells in the esophagus has previously received little attention, but in light of these 
findings, lineage studies to probe contributions to the esophagus from somitic versus 
lateral mesodenn should be of interest. 
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Fig. 1. Developmental and rostrocaudal progression from smooth to skeletal muscle in 
muscularis layer of mouse esophagus. Confocal microscope images of esophageal tissue 
sections and dissociated cells labeled with antibodies to smooth-muscle myosin light chain 
kinase (MLCK) shown in green and skeletal-muscle fast myosin heavy chain (MHC) 
shown in red (18). Co-localization of the two proteins appears as yellow. (A to F) 
Diaphragm-level (middle) sections of embryonic day 15 (E15) to postnatal day 14 (Pl4) 
esophagus. (D) is a higher magnification of the image shown in (C); the arrow points to a 
cell coexpressing both markers. (G and H) Upper and lower esophagus sections of P3 
animals, compare to middle section in panel (C). (I) Phase image of a group of P3 
dissociated esophageal cells. and (J to L) tluorescent images of this field of cells that show 
expression of the designated marker(s). Arrows in (I to L) point to a cell that is expressing 
both skeletal and smooth muscle marker. Dissociation experiments were carried out by 
gentle mechanical disruption of tissue as well as a collagenase and dispase treatment for 15' 
at 37oc. The objective of this treatment was to dissociate the cells to a level that insures 
observing single-cell populations but at the same time to avoid massive cell death due to 
excessive insult. Abbreviations: d, diaphragm; e, esophagus; m.m., muscularis mucosae; 
s. stomach; NB, newborn. The size bars in (A to C, and E to H) represent lOOµm, while 
in (D, and I to L) they represent 5µm. 
00 ......, 
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Fig. 2. Expression of smooth muscle-specific marker precedes expression of the 
myogenic regulatory factors (MRFs) during development of esophagus muscularis tissue. 
Transverse sections of E15 and P3 embryos through diaphragm-level (middle) esophagus 
are colabeled with myogenin and smooth MLCK (A. C and D) or MyoD and smooth 
MLCK (B). (D) is a higher magnification of (C) and shows cells that co-express nuclear 
myogenin and cytoplasmic MLCK (arrows). Abbreviations: d, diaphragm. e, esophagus. 
The size bars represent 50µm. 
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Fig. 3. The state of cell death and cell proliferation during perinatal development of 
mouse esophagus. (A and B) Diaphragm-level (middle) esophagus sections through a P6 
embryo were colabeled with pmpidium iodide (P.I.) and skeletal MHC (A) or smooth 
MLCK (B). Pyknotic nuclei in propidium iodide labeled sections were readily recognized 
by tluorescence microscopy: they were more brightly stained than normal nuclei, and are 
marked here with arrows. (A) The two top arrows show pyknotic nuclei in the non-muscle 
layer of squamous epithelium of esophagus; the arrow at the bottom points to an 
apoptosing cell in the muscularis layer (m) that does not stain for skeletal MHC. (B) The 
pyknotic cell (arrow) in the muscularis layer does not express smooth MLCK. Propidium 
iodide staining was achieved as described previously (19), and visualized with TRITC 
optics. In brief, tissues were fixed in 4% paraformaldehyde, sectioned, stained for muscle-
specific antibodies, and then incubated with 4µg of propidium iodide (Sigma) and 
lOOµg/ml RNase (Sigma; DNase free) in PBS for 30 minutes at 37°C. (C to F) Upper 
esophagus sections from El 8 embryos in-vivo labeled with 5-bromo-2'-deoxy-uridine 
(BrdU) were costained with BrdU antibody together with skeletal MHC (C and D) or 
smooth MLCK (E and F) antibodies. (D) and (F) are higher magnifications of the images 
shown in (C) and (F). respectively. BrdU labeling was achieved by injecting a female at 
El 8 gestation with 20µ1 of lOmM BrdU per gram of body weight (Boehringer Mannheim, 
#1299964). After 4 hours, the animal was sacrificed, and the embryos were frozen and 
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SUMMARY 
In developing mouse embryos MyoD family regulatory genes are expressed specifically in 
muscle precursors and mature myofibers. This pattern, taken together with the well-
established ability of MyoD family members to convert a variety of cell types to skeletal 
muscle, suggests a significant role for these genes in regulating skeletal myogenesis. The 
possibility that expression of these genes may be causally associated with segregation of 
the myogenic lineage from other mesodermal derivatives, or with the subsequent 
maintenance of muscle phenotypes at later times, raises the issue of how MyoD family 
genes are themselves regulated during development In this work, we have initiated studies 
to identify DNA sequences that govern Myf-5 and MRF4 (herculin, myf-6) transcription. 
Myf-5 is the first of the MyoD family to be expressed in the developing mouse embryo, 
while MRF4 is the most abundantly expressed myogenic factor in postnatal animals. In 
spite of their strikingly divergent patterns of expression, Myf-5 and MRF4 are tightly 
linked in the mouse genome; their translational start codons are only 8.5 kilobases apart. 
Here, the 5' flanking regions of the mouse Myf-5 and MRF4 genes were separately linked 
to a bacterialj3-galactosidase (lacZ) gene, and these constructs were each used to produce 
several lines of transgenic mice. Transgene expression was monitored by X-gal staining of 
whole embryos and by in situ hybridization of embryo sections. For the Myf-5/LacZ lines, 
the most intense transgene expression was in the visceral arches and their craniofacial 
muscle derivatives, beginning at day 8.75 post coitum (p.c.). This correlates with 
endogenous Myf-5 expression in visceral arches. However, while Myf-5 is also expressed 
in somites starting at day 8 p.c., transgene expression in the trunk is not observed until day 
12p.c. Thus, the Myf-5/Lacz construct responds to early Myf-5 activators in the visceral 
arches but not in the somites, suggesting that myogenic determination in the nonsmoitic 
head mesoderm may be under separate control from that of the somitic trunk mesoderm. 
MRF4/LacZ lines displayed an entirely different pattern from Myf-5. Transgene 
expression appeared in muscles starting at day 16.5 p.c. and became increasingly 
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prominent at later times. However, an early wave of myotomal expression that is 
characteristic of the endogenous MRF4 was not recapitulated by the transgene. 
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INTRODUCTION 
Skeletal muscle is one of many derivatives of mesoderm in vertebrates. Muscles of the 
head originate from prechordal and paraxial mesodermal cells (Noden, 1991; Couly et al., 
1992), most of which populate the visceral arches and then migrate into the developing 
head. Muscles of the trunk and limbs arise from the somites, which are segmental blocks 
of paraxial mesoderm that form in pairs on either side of the neural tube (Lyons and 
Buckingham, 1992; Ordahl and Le Douarin, 1992). 
An important contribution to the current view of skeletal myogenesis came from the 
cloning of MyoD (Davis et al., 1987; Tapscott et al., 1988) and its three close relatives, 
myogenin (Wright et al., 1989; Edmondson and Olson, 1989), Myf-5 (Braun et al., 1989), 
and MRF4/herculin/Myf-6 (Rhodes and Konieczny, 1989; Miner and Wold, 1990; Braun 
et al., 1990). These genes encode transcription factors of the basic-helix-loop-helix (B-
HLH) family (Murre et al., 1989) that bind in vitro to consensus "E-box" recognition sites. 
These sites are prominent and functionally significant in many genes expressed specifically 
in differentiated muscle (Murre et al, 1989; Weintraub et al, 1991). Forced expression of 
any of the MyoD family genes in a variety of nonmuscle cultured cells can convert them to 
a skeletal muscle phenotype, suggesting that these regulators play a significant role in 
determination and differentiation of skeletal muscle (Olson, 1990; Weintraub et al., 1991). 
The ability of ectopic MyoD and/or Myf-5 to activate skeletal muscle-specific genes in 
developing Xenopus embryos (Hopwood and Gurdon, 1990; Hopwood et al., 1991) and 
the hearts of transgenic mice (Miner et al., 1992) supports this view. 
Analysis of the expression of these myogenic regulatory genes in several cultured 
skeletal muscle cell lines has revealed that proliferating myoblasts, which are determined to 
form muscle, express MyoD (MM14 [Mueller and Wold, 1989]). Myf-5 (L6, BC3Hl 
[Braun et al., 1989; Mueller and Wold, 1989]), or both (C2Cl2 [Braun et al, 1989; Miner 
and Wold, 1990]), while their differentiated conterparts express myogenin always 
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(Emerson, 1990) and MRF4 sometimes (L6Jl-C, C2C12 [Rhodes and Konieczny, 1989; 
Miner and Wold, 1990]). However, it is not at all clear how these few established cell 
lines are related to muscle and its progenitors in the animal. In situ hybridization 
experiments on mouse embryo sections have shown that there is a complex pattern of 
sequential accumulation and disappearance of MyoD family RN As in developing muscle, 
and that the pattern varies among different skeletal muscle groups (for review see 
Buckingham, 1992). Myf-5, the earliest marker of muscle, is first detected at 8 days p.c. 
in anterior somites, just before the myotome can be recognized as distinct from sclerotome 
and dermotome by cytological criteria (Ott et al., 1991). Similar expression is sequentially 
observed in more posterior somites as these structures form in their characteristic rostral-
caudal sequence. Myf-5 RNA is subsequently detected at day 9.25 p.c. in the hyoid arch 
and is followed at day 10 p.c. in the mandibular arch and at day Hl.5 p.c. in the forelimb 
bud. Myogenin and MyoD are expressed in all muscle masses following Myf-5 activation. 
In contrast, MRF4 is never detected in visceral arches or limb buds by in situ hybridization. 
However, a wave of tmnsient MRF4 RNA expression is observed in myotomes between 
days 9 and 11.5 p.c. (Bober et al., 1991; Hinterberger et al., 1991). Late in development, 
Myf-5 expression declines and becomes undetectable by day 14 p.c. and remains that way 
(Ott et al., 1991), while MRF4 reappears at day 16 p.c. in all fetal skeletal muscles and 
becomes the predominant MyoD family regulatory gene expressed in the adult (Rhodes 
and Konieczny, 1989; Miner and Wold, 1990; Bober et al., 1991; Hinterberger et al., 
1991). 
The basis for the complex and stringently controlled pattern of differential 
expression of the MyoD family of regulators is not well understood. Studies of genomic 
regulatory elements have mainly concentrated on the myogenin and MyoD genes. 
Remarkably, only 200 base pairs of proximal 5' tlanking sequence from the myogenin 
gene were sufficient to direct myocyte specific expression (Salminen et al, 1991). The 
emerging picture for human MyoD is quite different. Its 5' flank has been tested for 
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regulatory activity in both cell culture and in transgenic mice. Experiments in cultured cells 
led to the identification of a region positioned between 18 and 22 kb upstream of the coding 
region which enhanced transcription from the proximal MyoD promoter in 23A2 myoblasts 
but also, surprisingly, in their nonmyogenic parental cell line C3H lOTl/2, where 
endogenous MyoD is not normally expressed. In spite of the apparently inappropriate 
expression in nonmyogenic cultured cells, this enhancer element drove expression in a 
muscle-restricted pattern in transgenic mice (Goldhamer et al. 1992). 
In contrast to MyoD and myogenin, little is presently known about the regulation of 
MRF4 and Myf5. Myf-5 transcripts appear before any of the other MyoD family RN As 
(Ott et al, 1991). MRF4 is most notably expressed in late fetal and postnatal muscle where 
it quantitatively predominates over the other MyoD family transcripts (Miner and Wold, 
1990), suggesting a role for MRF4 in maintenance of differentiated muscle. Furthermore, 
the close physical linkage of Myf-5 and MRF4, presumably the result of an ancient gene 
duplication, presents an intere..~ting problem in the evolution, organization and utilization of 
regulatory elements. The two genes share a stringent specificity for expression in skeletal 
muscle, but show highly disparate developmental regulation. In preliminary experiments 
we found expression of reporter genes carrying Myf-5 and MRF4 flanking sequences in 
cultured cell lines to be minimal. To overcome this assay limitation and to gain access to 
the full developmental diversity of MRF4 and Myf-5 expressing cells in the animal, we 
have produced transgenic. These experiments have allowed us to identify sequence 
elements from Myf-5 and MRF4 that specify expression in their distinct, spatially and 
temporally restricted patterns. 
MATERIALS AND METHODS 
Construction of the transgenes 
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5.5 kb of the 5' flanking region of the mouse Myf-5 gene were isolated as a BamHI to Sacl 
fragment from the original mouse Myf-5/herculin phage described previously (Miner and 
Wold, 1990). This fragment contains the Myf-5 proximal promoter and putative 
transcription start site (Ott et al., 1991). A bacterialfl-galactosidase gene containing an 
introduced consensus Kozak translation initiation sequence was placed downstream of this 
in Bluescript II KS+ (Stratagene) to make MYF5Z. 
The original Myf-5/herculin phage contained only about 350 base pairs of herculin 
(MRF4) 5' flanking DNA. Genomic Southern blots (J.M., unpublished) had indicated the 
existence of another BamHI site approximately 10 kb upstream of the previously identified 
site (Miner and Wold, 1990), or 6.5 kb upstream of the MRF4 coding region. We cloned 
this 10 kb BamHl fragment by constructing a phage lambda library from -9-11 kb BamHI 
fragments of mouse genomic DNA (electroeluted from an agarose gel) using the vector 
lambda gem-12 (Promega). The library was probed with the MRF4 transcribed region, 
and the insert of a positive phage was subcloned into Bluescript II KS+. Restriction 
analysis showed that this phage contained the MRF4 coding region as well as 6.5 kb of 5' 
flanking DNA, as expected. To be sure of including the MRF4 transcription start site in the 
lacZ construction, we used the -6.5 kb BamHI to San fragment as a foundation and then 
ligated 52 base pairs of additional contiguous sequence, synthesized as two complementary 
oligonucleotides by the Caltech Microchemical Facility. This sequence was added because 
preliminary primer extension assays (J. fvi., unpublished) had indicated that it should 
contain the major transcription start site. Therefore, the 3' end of the mouse MRF4 
sequences used here is nucleotide 64 of the reported herculin genomic sequence (Miner and 
Wold, 1990). 
Preparation of DNA and production of transgenic mice 
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MYF5Z and MRF4Z plasmids were purified by cesium chloride density gradient 
ultracentrifugation. To liberate the constructs from vector sequences, MYFSZ was cut with 
Kpnl, BamHI, and Seal, and MRF4Z was cut with BamHI and Xhol. To isolate the 
fragments for microinjection, the restriction digests were loaded onto 10-40% preformed 
sucrose gradients and ultracentrifuged in a SW 41 rotor at 26,000 RPM for 24 hours 
(Maniatis et al., 1982). 300 µL fractions were collected and analyzed by agarose gel 
electrophoresis. DNA was ethanol-precipitated out of the appropriate fractions and 
dissolved in 10 mM Tris (pH=7.5), 0.1 mM EDTA (pH=8). Transgenic mice were 
produced by pronuclear microinjection of single cell mouse embryos from a 
(C57BL/6XDBA/2)F1X(C57BU6XDBA/2)Fl cross as described (Hogan et al., 1986; 
Miner et al., 1992). 
Analysis of transgenic mice 
Transgenic founder mice were identified by Southern blot or polymerase chain reaction 
analysis of tail DNA. Male founders and male offspring of female founders were mated in 
most cases with C57BU6 X DBA/2 hybrid females, though sometimes the parental inbred 
strains were used. For postnatal analyses, pups of various ages were sacrificed, skinned, 
fixed in 4% formaldehyde in phosphate buffered saline (PBS), and stained in PBS 
containing 35 mM potassium ferricyanide, 35 mM potassium ferrocyanide, 1.5 mM 
magnesium sulfate, and 1 mg/ml X-gal (US Biochemicals Corp.) overnight at 37oc. For 
prenatal analyses, timed pregnant females were sacrificed at the desired day of gestation, 
and embryos were dissected out of the uterine horns into PBS. They were fixed and 
stained as above, though for older embryos the staining solution was supplemented to 
contain 0.2% sodium deoxycholate and 0.1 % Nonidet P-40 to enhance X-gal penetration. 
In situ Hybridization 
In situ hybridization was performed on 5 to 7-µm paraffin sections. The procedures used 
for section treatment, hybridization, and washings are described by Lyons et al. (1990). 
Hybridizations were carried out at sooc for ~ 16hr in 50% deionized formamide, 0.3M 
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NaCl, 20mM Tris-HCI (pH 7.4). 5mM EDTA, lOmM sodium phosphate (pH 8), 10% 
dextran sulfate, lX Denhardt's solution, 50µg/ml of yeast RNA, with 50-75,000 cpm/µl of 
cRNA labeled with 35s-Iabeled UTP (>1000 Ci/mmole, Amersham). Washing was at 
650C in 50% formamide, 2XSSC, and lOmM OTT. Slides were then treated with RNase 
A (20µg/ml) (Boehringer Mannheim) for 30 min at 37oc. After washes, slides were 
processed for standard autoradiography with Kodak NTB-2 nuclear track emulsion and 
exposed for 7 days. Analysis was carried out with both light- and dark-field optics on a 
Zeiss Axiophot microscope. 
For the Myf-5 probe, a 310-bp Ball-Apal fragment of the first exon of the mouse 
Myf-5 gene was used as described by Ott et al. (1991). For the MRF4 probe, the 680-bp 
3' Pstl fragment of the mouse gene was used as described by Bober et al. (1991). For the 
lacZ probe, the 3kb BssHII fragment of the MRF4Z construct, which also contains the 
SV 40 polyadenylation signal sequence, was used. 
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RESULTS 
Production of transgenic mice 
5.5 kb of Myf-5 and 6.5 kb of MRF4 5' flanking regions were each linked to the bacterial 
fl-galactosidase gene. These constructs (Fig. 1) are called MYF5Z and MRF4Z, 
respectively. Multiple transgenic lines were produced by pronuclear microinjection. All 
four DNA-positive lines produced with the MYF5Z construct expressed the transgene; two 
of the four lines, MYF5Z-2 l and 29. showed the most intense lacZ staining and hence 
were more comprehensively characterized. The two other lines. MYF5Z-9 and MYF5Z-
46. showed an overlapping hut reduced expression pattern. Seven MRF4Z transgenic lines 
were produced: three (MRF4Z-28, 45 and 49) expressed the transgene in a muscle-specific 
manner, three did not express the reporter gene at all, and a single line. called MRF4Z-4. 
exhibited ectopic expression in several diverse tissues characteristic of strong. site-of-
insertion postilion effects (Allen et al; Gossler et al., 1989). 
MYFSZ trangenic mice 
To survey developmental expression patterns of the transgene in detail, we used 
histochemical staining for B-galactosidase beginning at day 8.75 p.c. (E8.75) and 
continuing through birth. This assay is highly sensitive. and parallel controls showed all 
staining, except in the gut of postnatal pups, to be specified by the activity of the transgene. 
The ES.75 (15 somites) embryos examined from MYFSZ-21 and 29. two of the best-
expressing lines, contained lacZ-positive cells in the hyoid and mandibular arches but not in 
somites (Fig. 2A). Since prior in situ hybridizations had shown that Myf-5 transcripts 
begin to accumulate in somites at ES.O and in visceral arches at E9.25 (Ott et al., 1991). it 
appears that this construct contains sequences sufficient to specify the early visceral arch 
expression. but insufficient to drive early somitic expression. As development proceeded, 
both the number of cells expressing lacZ and the intensity of expression increased. At 
El0.5, the hyoid arch exhibited very intense expression, and lacZ-positive cells were 
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visible in the developing ocular muscles (Fig. 2B). At E12, myotomal staining became 
detectable, then increased in intensity at El2.5 (Fig. 2C). Also at El2.5, staining was 
visible in the developing muscles of the head which are derived from the visceral arches 
and in the muscle masses of the proximal forelimb. When myotomal expression of the 
transgene becomes detectable, it already encompasses the full length of the embryo (Fig 
2C,D), so the anterior-posterior sequence of endogenous Myf-5 activation that corresponds 
to early myotome segregation is not recapitulated by the transgene. Transgene expression 
was most prominent at El3.5 with the appearance of lacZ-positive cells in the intercostal 
muscles and developing abdominal muscles (Fig. 20). Beginning at day 14, when 
endogenous Myf-5 RNA levels begin to decrease (Ott et al., 1991), muscle-specific lacZ 
expression declined and became undetectable shortly after birth (data not shown). The 
expression patterns described were present in at least two different transgenic lines (Fig. 
20,E), confirming that the transgene expression in these tissues resulted from regulatory 
elements present in the MYF5Z construct, not from site-of-integration position effects. 
This lacZ pattern retlects a substantial subset of the endogenous Myf-5 expression pattern 
as described previously by in situ hybridization (Ott et al, 1991). 
To compare endogenous and transgene expression directly, and to verify the 
sensitivity of the whole mount embryo X-gal staining assay, El 1.5 and El2.5 embryos 
from MYFSZ-21 and MYF5Z-29 transgenic lines were sectioned, and in situ hybridization 
experiments with Myf-5 and lacZ probes were performed on adjacent sections. The lacZ 
expression pattern observed in these experiments was identical to the whole-embryo X-gal 
staining pattern. In most cases Myf-5 and lacZ RNA distribution was similar, with lacZ 
representing a subset of the endogenous Myf-5 expression. At El 1.5 (Fig. 3A,B), head 
muscles were positive with both Myf-5 and lacZ probes, while somitic expression was 
observed only with the Myf-5 probe. At E12.5 (Fig. 3 C,D), trunk muscles as well as the 
proximal forelimb muscles expressed the transgene. 
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In individual MYFSZ transgenic lines, lacZ was expressed ectopically in a few 
non-skeletal muscle tissues (Fig. 28-D, 38,D), as observed by both whole-mount staining 
of embryos with X-gal and in situ hybridization experiments. Since these expression 
patterns were each characteristic of one line only, and not shared by any of the other three 
transgenic lines (Fig. 20,E), we suggest that the observed ectopic expression is probably 
due to enhancer elements trapped near the insertion site of the construct (Lacy et al., 1983; 
Kothary et al .• 1988; Al-Shawi et al.. 1990). 
MRF4Z transgenic mice 
Three MRF4Z lines expressed the lacZ transgene in multiple muscle groups beginning at 
E16 (data not shown). Expression of the transgene increased throughout the perinatal 
period (Fig. 4) in parallel with the observed pattern of endogenous MRF4 expression 
(Bober et al., 1991; Hinterberger et al., 1991). However, MRF4Z transgenic mice did not 
express the transgene transiently in embryonic myotomes as the endogenous MRF4 gene is 
expressed. 
Some muscles expressed the MRF4Z transgene more intensely than others. For 
example. muscles of the limbs showed faint lacZ staining (Fig. 4A), whereas the 
spinodeltoideus muscle (Fig. 4A), levator auris longus muscle (Fig. 4B), and intervetebral 
muscles (Fig. 4C) expressed lacZ particularly strongly. To compare the spatial distribution 
of the endogenous MRF4 and lacZ transcripts, abdominal muscles were dissected and in 
situ hybridization reactions were performed with MRF4 and lacZ probes on adjacent 
sections (Fig. 5). Both MRF4 and lacZ were positive in all muscle fibers, but showed no 
activity in the nearby connective tissue. 
Because three of four independent transgenic MRF4Z lines exhibited the same 
general patterns of lacZ expression, and because this pattern parallels that of endogenous 
MRF4, we attribute this expression to regulatory sequences present in the transgene. 
However, one MRF4Z line, MRF4Z-4, expressed lacZ in a different and unexpected 
fashion (Fig. 6). With the exception of the spinotrapezius muscle, which expressed 
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intensely starting at El6. MRF4Z-4 transgene expression did not correlate with the 
endogenous MRF4 pattern (Bober et al .• 1991; Hinterberger et al., 1991) or with the other 
MRF4Z lines. Instead, this line expressed lacZ in a variety of other tissues at different 
developmental time periods including vibrissae (Fig. 6A). hand pads, olfactory bulbs, knee 
and elbow joints (Fig. 6A), and mid-brain. This diversity suggests a dominant position 
effect coupled. perhaps, with damage to one or more copies of the transgene. 
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DISCUSSION 
The MyoD family of regulators have been inferred to play a significant role in skeletal 
myogenesis. Three lines of evidence support this idea. First, all four MyoD family 
members can recruit diverse cultured nonmuscle cells to a skeletal muscle phenotype 
(Olson, 1990; Weintraub et al .• 1991), and both MyoD and Myf-5 have been shown to be 
capable of activating skeletal muscle genes ectopically in developing embryos (Hopwood 
and Gurdon, 1990; Hopwood et al, 1991; Miner et al., 1992). This argues for a direct or 
indirect role for the MyoD family in the myogenic determination process. Second, 
molecular studies suggest a direct interaction between MyoD family regulators and 
transcriptional enhancers of many terminally differentiated muscle-specific genes (Olson, 
1990; Weintraub et al., 1991). This is consistent with a direct and ongoing role in 
execution and maintenance of terminal muscle differentiation. Finally, the MyoD family of 
transcription factors (most notably Myf-5) are expressed early in premuscle cells (Sassoon 
et al., 1989; Ott et al. 1991; Bober et al., 1991; Hinterherger et al., 1991), which 
reinforces a role for these regulators in myogenic determination prior to overt differentiation 
of muscle. However, little is known about the molecular and cellular processes that govern 
the segregation of the myogenic lineage from other mesodermal derivatives in the 
developing mouse embryo. If the activities of these MyoD family regulatory proteins are 
partly or wholly responsible for establishing the skeletal muscle phenotype, then learning 
how expression of these regulators is initiated, maintained, and terminated during 
embryogenesis is crucial for understanding how myogenic cell fate is specified and 
executed. Apart from the postulated importance of MyoD family products in regulating 
myogenesis, their complex and diverse patterns of expression during development make 
them very useful markers for distinct subdivisions of myogenic populations. 
Here we have identified DNA sequences from the My.f-5/MRF4 locus that direct 
expression of the bacterial.Jl-galactosidase gene in patterns reflecting that of endogenous 
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Myf-5 and MRF4. The MYF5Z transgenic mice, which carried 5.5kb of upstream Myf-5 
sequences, expressed the lacZ reporter gene in a large subset of the cells which express 
endogenous Myf-5 RNA. Myf-5, the earliest known marker for myogenic precursors, is 
initially expressed in a group of cells in somites and visceral arches which later become 
muscle cells of the trunk and head, respectively (Ott et al, 1991). Our results suggest that 
visceral arch expression of Myf-5 is under separate control from early Myf-5 expression in 
the somite, since we have shown that Myf-5 visceral arch regulation is recapitulated in our 
construct, but early somitic expression is not Although confirmation will require isolation 
of sequences that do direct early somitic expression, the clear implication is that there are 
distinct regulatory pathways by which Myf-5 expression, and perhaps muscle 
determination, is initiated in somitic trunk versus unsegmented head mesoderm. In a 
similar vein, expression of Myf-5 observed in our experiments subdivides somitic 
expression by time (early versus late) and by the subset of somitic Myf-5-positive cells that 
also show lacZ expression by in situ hybridization. In addition, the failure of this MYF5Z 
construct to be expressed when transfected into C2C12 cells (A.P., unpublished), which 
do express some endogenous Myf-5 (Miner and Wold, 1990), is consistent with the 
organization of Myj-5 control regions into multiple segregated regulatory elements and it is 
likely that only a subset of these are included in this construct. 
The MRF4Z transgenic mice expressed the transgene in muscle cells of embryos 
starting at El6.5, and the intensity of lacZ staining increased through the first week of 
postnatal development. This general expression pattern reflects that of endogenous MRF4 
as determined by in situ hybridization and Northern blot experiments (Bober et al., 1991; 
Hinterherger et al., 1991 ). However, endogenous MRF4 also displays a separate, transient 
expression pattern in myotome between E9-1 l.5 (Bober et al., 1991; Hinterherger et al., 
1991), hut we did not detect any somitic expression of the transgene in MRF4Z lines. 
Interestingly, this construct, when transfected into C2C 12 cells, which express some 
endogenous MRF4 upon differentiation (Miner and Wold, 1990), is active only in the 
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presence of high concentrations of cotransfected MyoD family regulatory factors (A.P., 
unpublished). Thus, for both MRF4 and Myf-5, sequences that normally regulate early 
myotomal as well as C2Cl2 transcription were apparently not included in the constructs. 
Of course there are additional mechanisms of regulation that may contribute to differences 
between transgene expression and endogenous RNA levels, including specific methylation 
of sequences within the transgene, or post-transciptional mechanisms such as RNA 
stability. It is also possible that all regulatory regions are present in our constructs but are 
dependent on the linked state of Myf-5 and MRF4. 
In these experiments some ectopic 8-galactosidase was observed in individual lines 
and was not reproduced in other transgenic lines with the same construct. This raises the 
general issue, crucial in experiments of this design, of proper attribution of transgene 
expression patterns. Two criteria were applied to assign expression to the elements from 
MRF4 and Myf-5. First, for any pattern attributed to the construct, transgene expression 
was observed in independent transgenic lines carrying the same construct, arguing that the 
signal was due to the construct itself and not to position effects at the site of insertion. The 
second criterion was to compare directly the transgene expression pattern with that of the 
endogenous gene by in situ hybridization. In this study, all elements of trans gene 
expression that were shared by multiple lines of transgenic mice from the same construct 
also correlated with RNA expression from their respective endogenous genes, supporting 
the idea that the elements used in these experiments represent true regulatory regions of 
Myf-5 and MRF4. in situ hybridization experiments were especially informative in the 
MRF4Z pups where penetrance of histochemical reagents into more mature muscle became 
a technical limitation. The line-specific ectopic transgene expression patterns were most 
likely due to adventitious enhancer trapping, in which the construct integrates near one or 
more endogenous, active genes, and the site of integration exerts some regulatory intluence 
over the transgene (Lacy et al., 1983; Kothary et al., 1988; Al-Shawi et al., 1990). Three 
of 11 lines displayed position effect phenomena at some stage of development, with two 
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other lines, MYF5Z-21 and MYF5Z-29, showing some ectopic expression together with 
the expected pattern. In the most extreme case, MRF4Z-4, the typical MRF4 pattern was 
almost entirely suppressed and a wide array of ectopic sites were substituted. Curiously 
expression in just one m~jor muscle, the spinotrapezius (Fig. 6), was very prominent, and 
correlated with the temporal regulation of the endogenous MRF4. 
Of the isolated regulatory elements, perhaps the most interesting is the Myf-5 5' 
flank, which responds to early signals in the developing head; it will be interesting to more 
narrowly define the sequences responsible. Since craniofacial muscles are derived from 
unsegmented paraxial mesoderm (Couty et al., 1992) and not from the somitic mesoderm 
that gives rise to trunk and limb muscles, a regulatory element that responds to early 
myogenic signals in the head hut not in the somites may ultimately permit molecular-level 
description of how these two myogenic lineages are differentially specified. Also, while 
cell culture experiments have shown that forced expression of any of the four MyoD family 
regulators can initiate a myogenic pathway, the issue of whether individual regulators are 
functionally different in vivo remains open and will require both gain-of-function and loss-
of-function manipulations. The cis-regulatory segments defined here should serve as 
effective tools for testing the in vivo consequences of specifically altering the expression 
pattern of myogenic regulators by, for example, expressing MRF4 in visceral arches and 
their derivatives. 
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Fig. 1. Structure of the mouse MRF4/Myf-5 locus and the respective transgenes. The 
stippled areas approximate transcribed regions, but for Myf-5 only the location of the first 
exon is known. Lacz segments are not drawn to scale. See Materials and Methods for 
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Fig. 2. Whole mount histochemical staining of MYF5Z embryos at various 
developmental stages. (A) A 15 somite (E8.75) MYFSZ-21 embryo. The hyoid arch and 
the mandibular arch are positive for lacZ activity. (B) El0.5 MYFSZ-21 embryo. The 
hyoid arch is the most intensely stained structure and staining is also visible in the 
mandibular arch and in the ocular muscles. Ectopic staining specific to MYFSZ-21 
embryos is observed in the nervous system as well as in the epithelium of the forelimb-
bud. (C) El2.5 MYFSZ-21 embryo. Staining is evident in muscular derivatives of the 
visceral arches, in the ocular muscles, in developing proximal forelimb muscles, and in the 
segmented myotomes. Additional ectopic expression is observed in the forebrain. (D) 
El3.5 MYFSZ-21 embryo. Staining is similar to that observed in (C). with additional 
muscle-specific staining in intercostal, proximal hindlimb, and dorsal neck and head 
muscles. Ectopic lacZ expression is observed in the ribs. (E) El3.5 MYFSZ-29 embryo. 
Muscle specific staining is identical to that observed in (D), indicating that this staining is 
due to regulatory sequences in the transgene and not those found at the site of integration. 
f, forebrain, h, hyoid arch, icm, intercostal muscles, m, mandibular arch, om, ocular 
muscles, r, rib, arrowhead, myotome. 
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Fig. 3. Expression of Myf-5 and lacZ in MYF5Z transgenic embryos as detected by in 
situ hybridization. (A,B) Parasagittal sections of El 1.5 MYF5Z-21 embryo hybridized to 
Myf-5 (A) and lacZ (B) probes. Both Myf-5 and lacZ are expressed in jaw Gm) and 
shoulder (sm) muscles, while only Myf-5 shows significant hybridization in intercostal 
muscles (icm), and tail somites (s) at this stage. While lacZ is expressed in ocular muscles 
(om), these muscles are not present in the more lateral section (A) probed with Myf-5. 
Notice that the pigment layer of the retina refracts under dark field illumination. Some 
ectopic expression of IacZ is observed in the neural tube (nt), dorsal ganglia (arrowheads), 
and surrounding the heart. (C,D) Frontal sections of an El2.5 MYF5Z-29 embryo 
hybridized to Myf-5 (C) and lacZ (D) probes. Both Myf-5 and lacZ are expressed in the 
back (bm) and limb muscles (lm), with limb muscles showing more intense signal with the 
Myf-5 probe than with the lacZ probe. The transgene also shows some faint ectopic 
expression in the heart (h) and neural tube (nt) which was not observed in the whole 
embryo X-gal assay. li, liver. Scale bar= 500 microns. 
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Fig. 4. Whole mount X-gal histochemical staining of MRF4Z postnatal mice. (A) A 
lateral view of the trunk of a two day-old MRF4Z-28 mouse pup. Most muscles of the 
trunk contain fibers that are positive for lacZ activity, including latissimus dorsi, pectoralis, 
and the abdominals. The spinodeltoideus muscle (s) is consistently the most intensely 
stained in MRF4Z transgenics; the limbs exhibit considerably less lacZ activity. (B) An 
enlarged dorsal view of the same pup showing staining in muscles of the head and the 
neck. (C) A dorsal view of the trunk of a seven day-old MRF4Z-45 pup. Most muscles 
are lacZ positive, staining is striking in the paired intervertebral muscles (arrowheads) 
along the anterior-posterior axis. The top is anterior in all three cases. 
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Fig. S. MRF4 and lacZ transgene expression in abdominal muscle sections of a 6.5 day 
old MRF4Z-45 trangenic pup as detected by in situ hybridization. (A) A phase-contrast 
micrograph of a section showing abdominal muscle fibers (m) associated with some 
adjacent connective tissue (ct). (B) Dark field micrograph of A hybridized with the lacZ 
probe. (C) Dark field micrograph of an adjacent section hybridized with the MRF4 probe. 
All muscle fibers are positive with both probes, while the connective tissue associated with 
the muscle is negative. Scale bar= 100 microns. 
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Fig. 6. Whole mount histochemical staining of the MRF4Z-4 transgenic mice 
demonstrates presumed insertion site-dependent expression specific to this transgenic line. 
(A) El5.5 embryo. Staining is evident in the vibrissae (whisker pads), around the opening 
of the mouth, and in connective tissue of the elbow and the knee. The only muscle staining 
observed in this line is in the spinotrapezius muscle of the back. (B) A dorsal view of the 
trunk of a two day-old pup showing intense staining of the spinotrapezius muscle of the 
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ABSTRACT 
Vertebrate skeletal muscle is derived from dorsal mesoderm. While trunk muscles are of 
somitic origin, many cranial muscles arise from cells of the rostral non-segmented paraxial 
mesoderm that migrate to visceral arches and later form muscles of the neck and face. In an 
initial comparative investigation, we measured expression of a panel of muscle-specific 
regulatory and differentiation genes in developing and adult head and trunk lineages. The 
MyoD family of myogenic regulatory factors (MRFs) play a crucial role in the formation 
and differentiation of all known skeletal muscle. In the trunk, prior studies have shown 
that expression of the first muscle difforentiation genes quickly follows expression of Myf-
5, the earliest marker for developing skeletal muscle in all lineages studied. In contrast, we 
find here that in the head lineage, expression of muscle-specific differentiation genes is 
significantly delayed relative to Myf-5. All other MRFs and downstream genes first appear 
about three days after Myf-5 expression is initiated. These results suggest that Myf-5 
activity is under sustained negative regulation in early cranial muscle precursors. In the 
adult head and limb muscles, no significant difforcnces in MRF expression was detected~ 
however, differential expression of specific myosin and actin isoforms was observed. One 
marked difference between head and trunk lineages is that MRF4 is not detectably 
expressed in head muscle precursors of the embryo. As an in vivo assay for its individual 
function, MRF4 was expressed in transgenic animals in early muscle precursors under the 
direction of Myf-5 head-specific cis-regulatory elements. This shift in MRF identity did 
not detectably perturh the normal cranial myogenic program. 
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INTRODUCTION 
During embryogenesis of vertebrates, multiple lineages of myoblasts originate from the 
dorsal mesoderm, differentiate, and ultimately fuse to form multinucleated myotubes 
(reviewed by Wachtler and Christ. 1992). All skeletal muscles of the trunk are derived 
from somites. the metameric units of paraxial mesoderm along the rostrocaudal axis of the 
trunk that characterize vertebrate embryos. The myotome, a compartment within the 
somite. is the first differentiated skeletal muscle mass to form in the embryo. A second 
myogenic lineage arises from the ventro-lateral region of limb-level somites and migrates 
into the limb buds where they later differentiate and fuse (reviewed by Ordahl and Le 
Douarin. 1992; Stockdale. 1992). In contrnst. muscles of the head are mainly derived from 
prechordal plate and anterior (non-segmented) paraxial mesoderm (reviewed by Couly et 
al.. 1992; Noden. 1991 ). A majority of these muscle precursors migrate ventrally to 
occupy the visceral arches before they migrnte again to their final position and difforentiate. 
The cloning and characterization of muscle-specific genes. both regulators and downstream 
differentiation markers. has been crucial to the study of myogenesis. The M.yogenic 
Regulatory Factors (MRFs) belong to the basic helix-loop-helix (b-HLH) class of 
transcription factors, and include Myf-5, MyoD. myogenin and MRF4/herculin/Myf-6 
(reviewed by Weintraub, 1993). The MRFs' roles in initiating and executing muscle 
differentiation in tissue culture is well characterized. Furthermore, they are required for 
muscle formation in vivo (Hasty et al., 1993; Nabeshima et al., 1993; Rudnicki et al., 
1993). Consistent with their roles in myogenesis, MRF expression in vivo is largely 
restricted to skeletal muscle precursors and mature myofibers. Within muscle precursors, 
the MRFs show distinct and dynamic expression patterns in different muscle lineages: Myf-
5 is the first of the MRFs to appear in the early myotomes, limb buds. and visceral arches 
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of mouse embryos; embryonic expression of MRF4. on the other hand, is restricted to 
myotomes only (reviewed by Lyons and Buckingham, 1992). Furthermore, the earliest 
MRF expression in the myotome is initiated dorsally, in close proximity to midline 
structures such as the neural tuhe and notochord which are important for induction of the 
myotome. In contrast, the visceral arch and limh muscle precursors begin expressing the 
MRFs and initiate myogenesis in a different cellular environment, after these cells have 
migrated laterally and ventrally towards their terminal destination. Recently, a close 
examination of the localization of the MRF proteins at the cellular level within the 
myotome, together with the analysis of germline deletions of Myf-5 and MRF4 have 
pointed towards an even more complicated scenario: different comhinations of MRFs are 
expressed in, and are required for, distinct suhdomains of the expanding myotome (Braun 
et al., 1994; Patapoutian et al., 1995; Smith et al., 1994 ). Similar situations could be 
present in the developing limb huds and visceral arches. 
Many muscle-specific differentiation genes contain binding sites for MRFs within their 
regulatory regions, and they an~ expressed in the developing skeletal muscle following the 
appearance of MRFs. Expression of the differentiation genes, both at the RNA and protein 
levels, is well characteiized in the myotome and limb huds of mouse embryos (reviewed by 
Lyons and Buckingham, 1992). Some of these, such as the skeletal and cardiac alpha actin 
isoforms are detectahle within half a day of Myf-5 expression in both myotomes and limb 
buds, while others commence expression at later times during differentiation. The 
expression pattern of the differentiation genes has not been previously characterired in the 
developing head muscle. In this study, using RT-PCR and immunotluorescence, we 
found that the earliest detectable muscle-specific differentiation gene expression begins in 
cranial muscle three embryonic days after Myf-5 is first detected: the lag in trunk somites is 
a half day, at most. This suggesl'i the presence of sustained negative regulation in head 
muscle precursors during this time point that keeps Myf-5 inactive for an extended period 
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of time. MRF4 is not expressed in the early head or limh hud lineages; and unlike the 
situation in myotomes. cells of the head lineage goes through extensive migration after 
becoming Myf-5 positive. hut before differentiating. To test il'i possible in vivo role. 
MRF4 was ectopically expressed in early cranial muscle precursors under Myf-5 regulatory 
sequences and find no overt change in the normal cranial myogenic pathway. 
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RESULTS 
Muscle-specific gene expression in head muscle precursors. 
To rapidly survey the expression of a large panel of muscle-specific regulatory and 
differentiation genes in the developing head muscle precursors. we used quantitative 
reverse transcriptase-polymerase chain reaction (RT-PCR). E7.5 whole mouse embryos; 
the head and trunk dissections of E8.5 to EI6.5 embryos; and three adult muscle groups, 
rectos femoris (thigh muscle). masseter (head muscle) and temporalis (head muscle) were 
the sources of total RNA used. Transcript levels from one gene to another cannot be 
compared using RT-PCR; however, relative levels of transcript'i from a given gene can be 
compared among different RNA samples if assay linearity is established. Thus, linearity of 
the RT-PCR over a substantial range of substrate RNA and PCR cycle number are crucial 
issues and were demonstrated in two sets of control experiments: First. cycle number 
titrations were performed with individual seti; of primers to ensure that the product was in 
linear range (data not shown); second, titmtions were carried out with varying amounts of 
initial input RNA to verify linearity with respect to starting material. One such control is 
shown in Fig. I, and demonstrates linearity of GAPDH product with respect to the amount 
of input RNA over a 100-fold range. 
As in the somites. different MRFs are expressed in the head in a characteristic temporal 
fashion during emhryogenesis. RT-PCR resulti; showed no detectable MRF expression in 
E7 .5 embryos at 26 cycles (Fig. 2). Under the same conditions of amplification, Myf-5 
was expressed at E8 in the trunk (Patapoutian et al.. 1995); myogenin, at E8.5; MRF4, at 
E9.5; MyoD, at EI0.5 (Fig. 2). In the head, Myf-5 was present at E8.5 which agrees with 
the onset of Myf-5 regulatory region activity in the visceral arches as visualized by a Myf-
5-lacZ reporter construct (Patapoutian et al., 1993). None of the other MRFs were 
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detectahle in the head hefore E 11.5 (Fig. 2). MRF4 did not begin to accumulate in the head 
muscle until El6.5 (Fig. 2). 
We next surveyed the expression of skeletal muscle differentiation genes in head and trunk 
at different embryonic stages. This panel consisted of FGF-6, M-Cadherin, a. skeletal 
actin, a. cardiac actin, different isoforms of myosin light chain (MLC IF, MLC3F, and 
MLCIA), different isoforms of myosin heavy chain (MHC-emhryonic, MHC-perinatal, 
MHC-adult, and MHC-~), the muscle specific form of neural cell adhesion molecule 
(NCAM-msd), muscle creatine kinase (MCK), gamma and epsilon subunits of 
acetylcholine receptors (ACHR-E and ACHR-y) and MEF-2C. Expression of these genes 
in the trunk have heen descrihed previously (Lyons and Buckingham, 1992), and the trunk 
RNA samples served here as controls. No muscle differentiation genes from this panel 
were detected in head samples before El 1.5 (Fig. 2 and data not shown), although the 
expression of Myf-5 reported above served as a positive control for the presence and 
detectahility of genes expressed specifically in the head myogenic lineage. Similarly, the 
absence of myogenin and a. skeletal actin in the head samples showed that the dissection of 
head from trunk (where these genes are active) was successful. 
To verify the RT-PCR results regarding the lack of early muscle-specific differentiation 
gene expression in the head lineage, we prohed EI0.5 and El 1.5 sections of visceral arch 
and myotomal domains with antibodies to a. actinin (Fig. 3) and myosin heavy chain (data 
not shown). While both differentiation markers were clearly expressed in myotomes at 
both timepoint<.;, the visceral arches showed expression only at El 1.5 and not at EI0.5, 
verifying the RNA-level analysis. 
Muscle-specific gene expression in adult head and trunk muscles. 
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To further investigate at later developmental times the distinctions between head and trunk 
lineages, we compared gene expression of two head muscle groups (masseter and 
temporalis) to a thigh muscle (rectus femoris) which is often used as the prototype adult 
muscle and serves here as a major representative of the appendicular lineage. Masserer and 
temporalis are both derived from lst arch mesoderm in the avian system. MRF gene 
expression. as well as MEF-2C and FGF-6 appeared equivalent in the adult samples tested 
(Fig. 4A). Also, while many of the muscle-specific differentiation genes described above 
appeared comparable, a few were differentially expressed (Fig. 4B and data not shown). 
Instead of the MHC-adult isofonn, adult masseter mainly expressed MHC-perinatal; both 
adult and perinatal isoforms were expressed at low levels in temporalis. ex. cardiac actin 
was almost completely undetectable in the head muscles (Fig. 4B), but was expressed at 
relatively higher levels in rectus fomoris. Thus, while known regulatory genes appear to be 
expressed at similar levels in head and limb muscles, RNA levels for several presumed 
downstream transcriptional target-; show significant differences. 
Ectopic expression of MRF4 in early head muscle precursors: 
Among the main difforences in MRF expression pattern between myotomes and visceral 
arches is the absence of MRF4 expression in head muscle precursors. To test for possible 
in vivo functional implications of this difference, we used cis-regulatory sequences from 
Myf-5 regulatory si::quences, described previously (Patapoutian et al., 1993), to drive the 
MRF4 gene in visceral arches. The Myf-5-MRF4 construct was coinjected with the 
previously descrihi::d MYF5Z (Patapoutian i::t al., 1993), which contains the same 
regulatory sequences driving the bacterial (3-galactosidase gene. We obtained two 
transgenic lines, one expressing hoth constructs (TgMRF4-l), and the other containing the 
Myf-5-MRF4 construct only (TgMRF4-2). Whole mount embryo staining of TgMRF4- l 
with X-gal showed lacZ staining in visceral arch muscle precursors beginning at E8.5, and 
the overall staining pattern was as previously reported (data not shown; Patapoutian et al., 
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1993). RT-PCR analysis demonstrated the presence of exogenous MRF4 in head muscle 
precursors in hoth transgenic lines (the reverse primer is from SV40 3' untranslated region) 
(Fig. 5. and data not shown). However. expression of other MRFs and skeletal 
differentiation markers appeared normal in the transgenic animals at different developmental 
timepoints (Fig. 5. and data not shown), indicating that combined Myf-5 (endogenous) and 
MRF4 (transgene) activity is not sufficient to drive premature myocyte differentiation or to 
alter the character of differentiated head muscle at later times. 
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DISCUSSION 
Two fundamental findings have made myogenesis an attractive system to study vertehrate 
cell type detennination and differentiation: the ahility to culture myohlasts and induce them 
to differentiate (Konigsberg. 1963), and the cloning of the MyoD gene and its relatives that 
have the potential to transform diverse permissive cell types into a myogenic phenotype in 
cell culture (Davis et al., 1987). Transfection assays have shown that all four MRFs have 
similar capahilities of activating the myogenic pathway. Results from cell culture studies 
led to a working model of myogenic regulation, in which MRFs (mainly Myf-5 and MyoD) 
are expressed in dividing myohlast~. hut their activity is negatively regulated until the onset 
of differentiation which is signaled hy expression of myogenin (reviewed hy Lassar et al., 
1994). Multiple mechanisms have heen shown to negatively modulate MRF activity in 
hiochemical assays and in cell culture systems: For example, Id family members, which 
are HLH proteins lacking a functional hasic region are present in myohlasltt and hind 
directly to the MRFs or their partners and repress their activity. Downregulation of Id-type 
molecules is ohserved under differentiation conditions, and this is thought to unleash the 
MRFs to carry out the myogenic differentiation process (Benezra et al.. 1990; Neuhold and 
Wold, 1993). Twist, another h-HLH molecule, can also act as a negative regulator of 
MRF activity hy directly hinding to the MRFs (Hehrok et al., 1994; Yun et al., 1995). C-
Jun, a leucine zipper class DNA hinding factor, can also hind to the MRFs in vitro and 
depress muscle differentiation in transfected cells in culture (Bengal et al., 1992). A 
second class of possible negative regulators of MRF action are kinases. Phosphorylation 
of the basic domain of the MRFs by protein kinase A and C inhihits DNA binding in vitro 
and can repress myogenesis in transfection assays (Li et al., 1992; Hardy et al.. 1993). 
More recently, a family of cyclins, presumably acting as components of cyclin dependent 
kinases (CDKs) associated with cdl cycle progression, have heen implicated as negative 
regulators of MRF function (reviewed hy Marx, 1995). 
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In addition lo the frnmidahle array of prospective negative modulators of MRF action, there 
is also evidence that one or more positive acting h-HLH co-regulators of the E-family are 
required for proper activity of MRFs (Weintraub et al., 1991 ). Although it remains an 
interesting possibility that MRFs, in some environments, may form homomeric complexes, 
their function in muscle differentiation is likely to require dimerization to positive E-type 
partners. The implication is that the absence of positive regulators in specific embryonic 
lineages could limit MRF action. Therefore, although the regulation of MRF activity has 
been thoroughly studied, a crucial issue is whether the picture of MRF modulation initially 
obtained from cell culture and biochemistry also applies to myogenic specification and 
differentiation in the developing mouse embryo. 
Possible negative regulation of Myf-5 in early head muscle precursors 
This study presento,; a survey of expression of various muscle regulators and differentiation 
genes in the head muscle lineage. We find that Myf-5 is expressed in visceral arches for 
three days before any other muscle-specific transcripts are detectable. The most 
straightforward explanation for this finding is that Myf-5 function is negatively regulated in 
head muscle precursors while these cells are in the visceral arches. However, the 
mechanisms of Myf-5 regulation are not clear. In vivo analysis of the expression pattern of 
MRFs, Id-1, and m-twist during myotomal development in the somite has shown that, to a 
large extent, a mutually exclusive expression pattern between the positive and negative 
HLH proteins (Wang et al., 1992; Wolf et al., 1991; Yun et al., 1995). Furthermore, the 
expression of some muscle-specific differentiation markers is detected only half a day after 
the initial appearance of Myf-5 in the myotome and limh-hud; the rapid kinetics and 
mutually exclusivity of MRF and negative HLH/hHLH factors argue against the extended 
use of global negative regulation of MRF activity in these lineages. Indeed, it is only the 
domain at the dorsomedial lip of the newly forming myotome that seems to express both m-
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twist and Myf-5 (Yun et al., 1995). In contrast, we ohserve in the head lineage a pattern of 
muscle-specific gene expression that may call for sustained negative regulation of Myf-5 in 
early visceral arches. It will now he of interest to monitor at high resolution the expression 
of potential negative regulators, such a-; Ids 1-4, m-Twist, and G-1 cyclins in the early 
head muscle precursors. The global negative regulation of Myf-5 in visceral arches 
nominates the head muscle lineage as the only emhryonic example reminiscent of the 
myogenic differentiation process in cell culture, where dividing myohlasts express MRFs 
for an extended period suhject to apparent negative regulation until the time of induced 
differentiation. A second explanation for extended Myf-5 expression without 
differentiation would he the lack of E-family positive-acting hHLH expression in the head 
lineage at early times. The unique modulation of Myf-5 activity in the head lineage might 
be due to the separation of induced commitment to myogenesis in visceral arches from the 
sites of muscle difterentiation that occurs later, after the complete migration of head muscle 
cells to the presumptive face. 
Differential expression of muscle-specific genes in adult head and trunk 
muscles 
The MRFs are transcription factors that can hind to regulatory sequences of muscle-specific 
genes and activate their expression. The MRFs are required for the expression of these 
differentiation genes in vivo (Hasty et al., 1993; Nabeshima et al., 1993; Rudnicki et al., 
1993). However, as observed previously from embryonic muscle-specific gene expression 
patterns. there is not a simple correlation between the timing of different MRF expression 
and the expression of putative downstream genes (reviewed by Lyons and Buckingham, 
1992). For example, although muscle creatine kinase (MCK) regulatory sequences are 
routinely accepted and used as a direct reporter of MyoD/myogenin activity in cell culture 
transfection assays, MCK is only expressed three days after MyoD and five days after 
myogenin in the developing mouse trunk. Similarly, comparison of gene expression 
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between head and limh adult muscle groups described here. shows that although MRFs and 
MEF-2C are expressed in a similar temporal fashion. major difforences in the expression of 
some muscle-specific differentiation genes exists between the two muscle groups: MHC-
perinatal, as it"i name implies, is an isoform of myosin heavy chain previously shown to he 
expressed in the trunk and limh muscles during perinatal stages of development; however, 
here we show that it is expressed prominently in adult head masseter muscle, while the 
normally expressed "adult" MHC isoform is virtually absent (Fig. 4). There are many 
possihle explanations for the differential expression of skeletal muscle-specific genes 
during various developmental times or within distinct muscle groups: Different affinities of 
cis-regulatory elemenL"i for individual MRFs and MEF-2s; methylation status and chromatin 
accessihility of individual regulatory element..; (Donogue and Sanes, 1994); or the 
differential presence of co-regulators (positive or negative) preferential for some muscle 
differentiation genes. It is clear from this work, however, that there exist a set of 
distinctions that correlate directly with head lineage vs. limb, and others that define 
different muscles within the hi.!ad. 
Ectopic expression of MRF4 does not effect the cranial myogenic program 
A major difference in gene expression between early head and trunk muscle precursors is 
the expression of MRF4 in myotomes compared to its complete absence from the visceral 
arches. In an attempt to detect a specific role for MRF4 expression in embryonic myocytes 
or their precursors, we ectopically expressed it in early head muscle precursors of 
transgenic mice by the previously described Myf-5 regulatory sequences. Exogenous 
MRF4 was properly expressed at the expected time in the heads of these transgenic mice; 
however, we did not oh.serve any molecular or physiological changes in these mice. 
Although a formal pos.sihility exisL"i that functional MRF4 protein is not present, it is 
unlikely since the RN A was present at high levels, and the same genomic MRF4 cassette 
has previously proven functional in cultured cell experiment'i (Miner and Wold, 1990). 
140 
The lack of phenotype observed at the earlier timepoints (E8.5 to El0.5) could he mainly 
due to the proposed sustained negative regulation of Myf-5. which might act on MRF4 as 
well. 
MRF4 knockouts have heen useful to elucidate the specific function of this gene during 
early emhryogenesis and adult lifo. Among other phenotypes, these mice show a severe 
downregulation of the embryonic isoform of myosin heavy chain (MHC-emh) which is 
expressed in myotomes concurrently with MRF4 (Braun and Arnold, 1995; Patapoutian et 
al., 1995; Zhang et al., 1995). However, as we show here, MHC-emh is expressed in 
wildtype head muscles at El 1.5, at least four days before MRF4 expression is detected 
there, suggesting that MRF4 is not necessary for embryonic head lineage expression of 
MHC-emh, even though it appears important for this gene in trunk and limh. The 
transgenic mice expressing ectopic MRF4 in head muscle precursors also showed normal 
levels of MHC-emh transcripts, and initial proper activation. Therefore, although the 
phenotype of MRF4 null mice suggesL'i that MRF4 is necessary for the expression of 
MHC-emh in some sub-lineages, the expression of MHC-emh in head lineage prior to 
MRF4 expression is consistent with the emerging view that no particular muscle-specific 
gene seems to he completely dependent on MRF4. 
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EXPERIMENTAL PROCEDURES 
RNA isolation and RT-PCR 
RNA was prepared by the method of Chomczynski and Sacchi (1987) from the trunk and 
head regions of embryos from difforent developmental timepoints and adult musculature. 
Quantitative RT-PCR was carried out according to the method of Robinson and Simon 
(l 991 ). Both reverse transcription and PCR were performed in the same tube in a single 
buffer with specific primers. AMV-RT (Promega) was used instead of MML V-RT, and in 
some cases Taq antibody (Clontech) was also added to block Taq polymerase activity at 
lower temperatures. 20-28 cycles were used for different primer sets (Table I). An initial 
titration was carried out to assure that amplifications at high cycle numbers were still in 
linear range. All primer seL'i were designed to span at least one intron to distinguish RNA 
from DNA contamination, and the sizes of the products were between 200 and 5(K) bases. 
Frozen sections and antibody staining 
Embryos were fixed in 4% paraformaldehyde at 4oc overnight. Embryos younger than el I 
were sunk into 15% sucrose & 7.5% gelatin in PBS solution and then frozen in OCT 
(Tissue-Tek). Older embryos were immediately frozen in OCT. Sections of I0-20µm 
thickness were obtained using a cryostat, and were hlocked for 20 minutes in 10% goat 
serum and 3% BSA in PBS before applying the primary antibody for 1-3 hours at room 
temperature. The secondary antibody solution was applied for 1 hour. Antibodies against 
myosin heavy chain, (MF20; l :10 dilution; mouse IgG2b; Developmental Studies 
Hybridoma Bank), striated muscle specific a actinin ( 1 :4(K) dilution; mouse lgG I; Sigma), 
were used. Secondary antibodies were conjugated to Fluorescein and specific to mouse 
IgG isotypes and used as 1: 100 dilution in 3% BSA in PBS (Southern Biotechnology 
Associates). 
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Production and analysis of transgenic mice 
The 5.5 kb of the 5' flanking region of the mouse Myf-5 gene as described previously 
(Patapoutian et al., 1993) was used to drive the MRF4 (herculin) gene attached to an SV40 
3' untranslated region (Miner and Wold, 1990). This construct, MYF5-MRF4, was then 
cut to isolate it from vector sequences, run on an agarose gel and purified by Qiaex Gel 
Extraction Kit (Qiagen). DNA was eluted in IO mM Tris (pH=7 .5), 0.1 mM EDTA 
(pH=8). This construct mixed with MYF5Z (Patapoutian et al., 1993) was used for 
pronuclear microinjection of single cell mouse embryos from a (C57BU6XDBA/2)Fl X 
(C57BU6XDBA/2)Fl cross as described (Hogan et al., 1986) and two independent 
transgenic founder lines were obtained. One of these lines contained only the 
MYF5-MRF4 construct (TgMRF4- l ), while the other contained both constructs 
(TgMRF4-2). Transgenic mice and embryos were identified by polymerase chain reaction 
(PCR) analysis of tail or placenta DNA. lµg of genomic DNA was used in 29 cycles of 
amplification with forward: CCAGAAGGCCACCGAGCAGGTT AG (from Myf-5 
promoter) and reverse: CCCTGGATACAAAGGAGAGCCCTC (from MRF4 exon 1) 
primers. Male transgenic animals were mated in most cases with C57BU6 X DBA/2 hybrid 
females to propagate the line or to obtain transgenic embryos. 
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Figure 1. Linear dependence of the output signal on input RNA during the amplification 
of control GAPDH. Seven RNA samples of two-fold serial dilutions from two separate 
head muscle groups were subjected to the RT-PCR protocol with primers to GAPDH at 24 
cycles. The products were quantitated using a Molecular Dynamics phosphorimager and 
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Figure 2. Myf-5 is the only muscle-specific gene to be expressed in head muscle 
precursors before El 1.5. Total RNA was made from head and trunk dissections from 
various stage embryos and subjected to the RT-PCR protocol with various primers to 
muscle-specific genes at different cycle numbers (see table I). (*) E7.5 represents RNA 
from the whole embryo. 
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Figure 3. Skeletal muscle-specific a actinin is not expressed in visceral arches prior to 
El 1.5. Transverse sections of El0.5 (A, B) and El l.5 (C, D) wildtype embryos were 
probed with an antibody against a actinin. Expression in visceral arches was observed at 
El 1.5 (C) but not at El0.5 (A). a actinin was expressed in myotomes of thoracic region at 





Figure 4. Expression of muscle-specific gene expression in adult head musculature. RT-
PCR from rectus femoris (thigh muscle), masseter (head muscle), and temporalis (head 
muscle) of adult mice was performed with primers to GAPDH control, muscle-specific 
regulators (A) and downstream differentiation markers (B). Most of the regulators are 
expressed comparably among the three samples. MHC isoforms and a cardiac actin are 
differentially expressed. 
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Figure 5. Expression of muscle-specific gene expression in transgenic mice containing 
the Myf5-MRF4 construct (TgMRF4-l). RNA from Ell.5 Head of transgenic and 
wildtype littermates were used for this RT-PCR assay. Endogenous MRF4 was not 
expressed at this time. however, exogenous MRF4 was only detectable in the transgenic 
sample. No other major difference in gene expression is detectable at this time. 
Abbreviations: exo., exogenous; endo., endogenous; emb., embryonic; MLClF. myosin 
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